Blue Sphere (BLSP) S-1/A 7 Mar 17 2016 FY IPO registration (amended) Financial data

Document and Entity Information

Document and Entity Information	12 Months Ended
	Dec. 31, 2016
Document And Entity Information
Entity Registrant Name	BLUE SPHERE CORP.
Entity Central Index Key	1,419,582
Document Type	S1
Document Period End Date	Dec. 31, 2016
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2,016

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
CURRENT ASSETS:
Cash and cash equivalents	$ 416	$ 1,888
Related Parties	1,408	1,378
Other current assets	81	37
Total current assets	1,905	3,303
PROPERTY, PLANT AND EQUIPMENT, net of accumulated depreciation	50	30
INVESTMENTS IN NOCONSOLIDATED AFFILIATES	10,137	7,570
INVESTMENTS IN NON-CONSOLIDATED SUBSIDIARIES	4,429	4,993
Total assets	16,521	15,896
CURRENT LIABILITIES:
Current maturities of Debentures and long term loan	2,988	549
Short term loan	280
Accounts payables	557	124
Other accounts payable	2,091	1,083
Deferred revenues from nonconsolidated affiliates	5,658	9,052
Total current liabilities	11,574	10,808
ACCRUED SEVERANCE PAY	11
LONG TERM BANK LOAN	112	127
LONG TERM LOANS AND LIABILITIES	5,003	5,543
DEBENTURES		2,360
WARRANTS LIABILITY	2,045	544
COMMITMENTS AND CONTIGENCIES (Note 10)
TOTAL LIABILITIES	18,745	19,382
STOCKHOLDERS' DEFICIT:
Common shares of $0.001 par value each: Authorized: 1,750,000,000 shares at December 31, 2016 and 2015. Issued and outstanding: 279,151,681 shares and 180,502,443 shares at December 31, 2016 and December 31, 2015, respectively.	279	1,256
Proceeds on account of shares		165
Treasury shares	(28)	(28)
Accumulated Other Comprehensive Income	33
Additional paid-in capital	43,985	39,813
Accumulated deficit	(46,493)	(44,692)
Total Stockholders' Deficit	(2,224)	(3,486)
Total liabilities and Stockholders' Deficit	$ 16,521	$ 15,896

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 31, 2016	Dec. 31, 2015
Consolidated Balance Sheets
Common shares, par value (in dollars per share)	$ 0.001	$ 0.001
Common shares, shares authorized	1,750,000,000	1,750,000,000
Common shares, shares issued	279,151,681	180,502,443
Common shares, shares outstanding	279,151,681	180,502,443

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2016	Sep. 30, 2015
Consolidated Statements Of Operations
Revenue from Services		$ 588
OPERATING EXPENSES -
General and administrative expenses	$ (1,106)	(7,516)	$ (5,317)
OPERATING LOSS	(1,106)	(6,928)	(5,317)
Financial Expense (Income), net	(75)	1,728	2,145
Loss (gain) from Change in Fair Value of Warrants Liability	219	(1,390)
NET LOSS BEFORE INCOME TAXES AND EQUITY EARNINGS (LOSSES)	(1,250)	(7,266)	(7,462)
Income Taxes		(52)
Equity Earnings in Unconsolidated Affiliates		5,961
Equity Losses in Non-Consolidated Subsidiaries	(38)	(444)
NET LOSS	$ (1,288)	$ (1,801)	$ (7,462)
Net loss per common share - basic and diluted ( in dollars per share)	$ (0.007)	$ (0.008)	$ (0.088)
Weighted average number of common shares outstanding during the period - basic and diluted (in shares)	177,011,554	235,909,374	85,135,631

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS $ in Thousands	12 Months Ended
	Dec. 31, 2016USD ($)
Income Statement [Abstract]
NET LOSS	$ 1,801
Other comprehensive loss, net of tax:
Currency translation adjustments	(33)
TOTAL COMPREHENSIVE LOSS	$ 1,768

STATEMENTS OF CHANGES IN SHAREH

STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (DEFICIT) - USD ($) $ in Thousands	Common Stock, $0.001 Par Value [Member]	Proceeds on account of shares [Member]	Treasury Shares [Member]	Additional paid-in Capital [Member]	Accumulated other comprehensive income [Member]	Accumulated deficit [Member]	Total
Balance beginning at Sep. 30, 2014	$ 1,126	$ 20		$ 35,106		$ (35,942)	$ 310
Balance beginning (in shares) at Sep. 30, 2014	50,109,036
Increase (Decrease) in Stockholders' Deficiency [Roll Forward]
Share based compensation				558			558
Issuance of common stock, net of issuance cost	$ 9			338			347
Issuance of common stock, net of issuance cost (in shares)	9,338,682
Issuance of common stock in respect of issuance of convertible notes	$ 76			1,449			1,525
Issuance of common stock in respect of issuance of convertible notes (in shares)	75,532,381
Issuance of shares for services	$ 33			1,541			1,574
Issuance of shares for services (in shares)	33,116,550
Issuance of convertible debentures				482			482
Treasury shares purchases			$ (28)				(28)
Treasury shares purchases (in shares)	(144,054)
Comprehensive loss						(7,462)	(7,462)
Balance ending at Sep. 30, 2015	$ 1,244	20	(28)	39,474		(43,404)	(2,694)
Balance ending (in shares) at Sep. 30, 2015	167,952,595
Increase (Decrease) in Stockholders' Deficiency [Roll Forward]
Issuance of common stock, net of issuance cost	$ 10			205			215
Issuance of common stock, net of issuance cost (in shares)	10,114,848
Issuance of shares for services	$ 2			134			136
Issuance of shares for services (in shares)	2,435,000
Comprehensive loss					$ (1,288)		(1,288)
Proceeds on account of shares		145					(145)
Balance ending at Dec. 31, 2015	$ 1,256	165	(28)	39,813		(44,692)	$ (3,486)
Balance ending (in shares) at Dec. 31, 2015	180,502,443						180,502,443
Increase (Decrease) in Stockholders' Deficiency [Roll Forward]
Share reverse split	$ (1,075)			1,075
Extinguish of liability upon shares issuance	$ 21			1,506			$ 1,527
Extinguish of liability upon shares issuance (in shares)	20,936,596
Issuance of common stock, net of issuance cost	$ 55	(20)		682			717
Issuance of common stock, net of issuance cost (in shares)	55,581,900
Issuance of shares for services	$ 7			738			745
Issuance of shares for services (in shares)	7,508,000
Exercise of warrants	$ 1			40			41
Exercise of warrants, shares	700,000
Comprehensive loss					33	(1,801)	(1,768)
Issuance of shares with respect to proceeds on account of shares	$ 14	$ (145)		131
Issuance of shares with respect to proceeds on account of shares (in shares)	13,930,742
Balance ending at Dec. 31, 2016	$ 279		$ (28)	$ 43,985	$ 33	$ (46,493)	$ (2,224)
Balance ending (in shares) at Dec. 31, 2016	279,159,681						279,151,681

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2016	Sep. 30, 2015
CASH FLOWS FROM OPERATING ACTIVITIES:
Profit (Net loss) for the period	$ (1,288,000)	$ (1,801,000)	$ (7,462,000)
Adjustments required to reconcile net loss to net cash used in operating activities:
Share based compensation expenses		1,181,000	558,000
Depreciation	1,000	17,000	6,000
Capital loss from disposal of property, plant and equipment		12,000
Expenses in respect of Convertible notes and loans	26,000	162,000	1,949,000
Equity earnings in Nonconsolidated Affiliates		(5,961,000)
Equity losses in nonconsolidated subsidiary	38,000	444,000
Issuance of shares for services	136,000	745,000	1,574,000
Changes in Warrants Liability	219,000	(1,338,000)
Amortization of projects cost			469,000
Expenses in respect of severance pay		11,000
Impairment of Investment			(22,000)
Decrease (Increase) in related parties	(1,378,000)	(80,000)
Decrease (Increase) in other current assets	(16,000)	(33,000)	244,000
Increase in deferred revenues from in Nonconsolidated Affiliates			1,482,000
Increase (decrease) in accounts payables	66,000	439,000	46,000
Increase in other account payables	71,000	1,383,000	338,000
Net cash used in operating activities	(2,125,000)	(4,819,000)	(818,000)
CASH FLOWS FROM INVESTING ACTIVITIES:
Investment in nonconsolidated subsidiary	(2,143,000)
Purchase of property and equipment		(60,000)	(37,000)
Net cash used in investing activities	(2,143,000)	(60,000)	(37,000)
CASH FLOWS FROM FINANCING ACTIVITIES:
Short Term Loans		750,000
Proceeds from issuance of debenture			625,000
Proceeds from issuance of debentures and warrants	2,672,000
Proceeds from loans	3,183,000	50,000	859,000
Proceeds from exercise of warrants		41,000
Repayment of loans and convertible debentures	(5,000)	(449,000)	(1,081,000)
Proceeds from issuance of shares and warrants		3,001,000	315,000
Proceeds on account of shares	145,000
Net cash provided by financing activities	5,995,000	3,393,000	718,000
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	1,727,000	(1,486,000)	(137,000)
EFFECT OF CHANGES IN EXCHANGE RATES ON CASH BALANCES IN FOREIGN CURRENCIES		14,000
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	161,000	1,888,000	298,000
CASH AND CASH EQUIVALENTS AT END OF PERIOD	1,888,000	416,000	161,000
NON-CASH TRANSACTION:
Loans exercised into Common Stock	188,000
Increase Investment in nonconsolidated subsidiary in consideration of Long Term Loan	4,236,000
Increase in investments in nonconsolidated affiliates against deferred revenues	2,618,000	2,133,000	4,952,000
Extinguish of debt upon shares issuance		373,000
Issuance expense paid through Common Stock		225,000
Proceeds on account of shares exercised into Common Stock		229,000
Cash paid during the period for:
Interest	$ 4,000	$ 621,000	$ 172,000

GENERAL

GENERAL	12 Months Ended
	Dec. 31, 2016
Accounting Policies [Abstract]
GENERAL	NOTE 1 – GENERAL a. General Blue Sphere Corporation (the “Company”), together with its wholly-owned subsidiaries, Eastern Sphere Ltd. (“Eastern”), BinoSphere LLC (“Binosphere”), Bluesphere Pavia S.r.l (“Bluesphere Pavia”, formerly called Bluesphere Italy S.r.l.), Sustainable Energy Ltd. (“SEL”), and Blue Sphere Brabant B.V. (“BSB”), is focused on project integration in the clean energy production and waste to energy markets. The Company was incorporated in the state of Nevada on July 17, 2007 and was originally in the business of developing and promoting automotive internet sites. On February 17, 2010, the Company conducted a reverse merger, name change and forward split of its common stock, and in March 2010 current management took over operations, at which point the Company changed its business focus to become a project integrator in the clean energy production and waste to energy markets. On May 12, 2015, the Company formed Bluesphere Pavia, a subsidiary of Eastern, in order to acquire certain biogas plants located in Italy (see note 5 below). On September 19, 2016, the Company formed BSB in order to commence operations in the Netherlands. As of December 31, 2016, SEL had not commenced operations. On January 31, 2017, we dissolved Johnstonsphere LLC, which had no operations since inception. b. Going concern consideration The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As of December 31, 2016, the Company had approximately $416 thousand in cash, a negative working capital of approximately $9,669 thousand, a stockholders’ deficit of approximately $2,224 thousand and an accumulated deficit of approximately $46,493 thousand. Management anticipates their business will require substantial additional investments that have not yet been secured. The Company anticipates that the existing cash will not be sufficient to continue its operations through the next 12 months. Management is continuing in the process of fund raising in the private equity and capital markets as the Company will need to finance future activities and general and administrative expenses. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. Company’s ability to continue as a going concern is dependent upon raising capital from financing transactions and revenue from operations. These financial statements do not include any adjustments that may be necessary should the Company be unable to continue as a going concern. The Company’s continuation as a going concern is dependent on its ability to obtain additional financing as may be required and ultimately to attain profitability.

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2016
Accounting Policies [Abstract]
SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES a. Functional currency The functional currency of the company is U.S dollar. The functional currency of the subsidiaries is also U.S dollar, except for Blue Sphere Pavia. Accordingly, all monetary assets, liabilities, expenses and equity earnings of the foreign subsidiary are re-measured into U.S. dollars at the exchange rates in effect at the reporting date. The foreign currency translation adjustments are included as a component in the stockholders’ Deficit in the accompanying consolidated balance sheet as a component of accumulated other Comprehensive Loss. b. Basis of Presentation The consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and includes the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. c. Cash equivalents Cash equivalents are short-term highly liquid investments which include short term bank deposit (up to three months from date of deposit), that are not restricted as to withdrawals or use that are readily convertible to cash with maturities of three months or less as of the date acquired. d. Fair Value of Financial Instruments The Company records its financial assets and liabilities at fair value. The accounting guidance for fair value provides a framework for measuring fair value, clarifies the definition of fair value, and expands disclosures regarding fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The accounting guidance establishes a three-tiered hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value: Level 1 – Quoted prices in active markets for identical assets or liabilities. Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The Company recognizes transfers among Level 1, Level 2 and Level 3 classifications as of the actual date of the events or change in circumstances that caused the transfers. The Company’s financial instruments, including cash equivalents, accounts payable and accrued liabilities have carrying amounts which approximate fair value due to the short-term maturity of these instruments. e. Property, plant and equipment Property, plant and equipment are stated at cost, less accumulated depreciation. Assets are depreciated using the straight-line method over their estimated useful lives. Annual rates of depreciation are as follows: % Computers, electronic equipment and software 33 Vehicles 15 Office furniture and equipment 15 f. Investment in nonconsolidated affiliates Investments in companies in which the Company has the ability to exert significant influence over operating and financial policies (generally 20% to 50% ownership), but which the Company does not control, are accounted for using the equity method. Under the equity method, investments are initially recorded at cost and adjusted for dividends and undistributed earnings and losses. The Company evaluates its investments in nonconsolidated Affiliates for impairment whenever events or changes in circumstances indicate that the carrying value of such investments may have experienced a decline in value. When there is evidence of loss in value that is other than temporary, the Company compares the estimated fair value of the investment to the carrying value of the investment to determine whether impairment has occurred. If the estimated fair value is less than the carrying value, the excess of the carrying value over the estimated fair value is recognized as an impairment loss. g. Use of estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results may differ from those estimates. On an on-going basis, management evaluates its estimates, judgments and assumptions. Those estimates and assumptions affect including investments in nonconsolidated affiliates, investments in non-consolidated subsidiaries, deferred revenue from nonconsolidated affiliates, contingencies and litigation, income taxes and determination of fair value of stock-based compensation. These estimates are based available as of the date of the consolidated financial statements; therefore, actual results could differ from management’s estimates. h. Loss per share Net loss per share, basic and diluted, is computed on the basis of the net loss for the period divided by the weighted average number of common shares outstanding during the period. Diluted net loss per share is based upon the weighted average number of common shares and of common shares equivalents outstanding when dilutive. Common share equivalents include: (i) outstanding stock options under the Company’s share incentive plan and warrants which are included under the treasury share method when dilutive, and (ii) common shares to be issued under the assumed conversion of the Company’s outstanding convertible notes, which are included under the if-converted method when dilutive. The computation of diluted net loss per share for the years ended December 31, 2016 and September 30, 2015 and for the three months period ended December 31, 2015 does not include common share equivalents, since such inclusion would be anti-dilutive. i. Income taxes The Company account for income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in Company’s consolidated financial statements or in our tax returns. Estimates and judgments occur in the calculation of certain tax liabilities and in the determination of the recoverability of certain deferred income tax assets, which arise from temporary differences and carryforwards. Deferred income tax assets and liabilities are measured using the currently enacted tax rates that apply to taxable income in effect for the years in which those tax assets are expected to be realized or settled. Management regularly assess the likelihood that deferred tax assets will be recovered from future taxable income and, to the extent that management believe, based upon the weight of available evidence, that it is more likely than not that all or a portion of deferred tax assets will not be realized, a valuation allowance is established through an adjustment to income tax expense. The factors used to assess the likelihood of realization of our deferred tax assets include the Company’s forecast of future taxable income and available tax planning strategies that could be implemented to realize the net deferred tax assets. Assumptions represent management’s best estimates and involve inherent uncertainties and the application of management’s judgment. The Company account for uncertainty in income taxes recognized in the Company’s consolidated financial statements by regularly reviewing our tax positions and benefits to be realized. The Company’s recognize tax liabilities based upon management’s estimate of whether, and the extent to which, additional taxes will be due when such estimates are more-likely-than-not to be sustained. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained upon examination by taxing authorities. The provision for income taxes includes the effects of any resulting tax reserves, or unrecognized tax benefits, that are considered appropriate as well as the related net interest and penalties. j. Comprehensive loss Comprehensive income (loss) consists of net income (loss) and other gains and losses affecting equity that under US GAAP are excluded from net income (loss). For the Company, such items consist of translation adjustments. k. Revenues from Services The Company recognizes revenues from Development Fees in accordance with ASC Topic 605-20 Revenue Recognition from Services. l. Treasury shares Treasury shares are held by the Company and presented as a reduction of the Company shareholders’ deficit and carried at their cost to the Company, under treasury shares. m. Stock-based compensation The Company recognizes the estimated fair value of share-based awards under stock-based compensation cost. The Company measures compensation expense for share-based awards based on estimated fair values on the date of grant using the Black-Scholes option-pricing model. This option pricing model requires estimates as to the option’s expected term and the price volatility of the underlying stock. The Company measures compensation expense for the shares based on the market value of the underlying stock at the date of grant, less an estimate of dividends that will not accrue to the shares holders prior to vesting. The Company elected to recognize compensation cost for awards that have a graded vesting schedule using the straight-line approach. Share-based payments to non-employees are measured at the fair value of the goods or services received or the fair value of the equity instruments issued if it is determined the fair value of the goods or services cannot be reliably measured, and are recorded at the date the goods or services are received. The amount recognized as an expense is adjusted to reflect the number of awards expected to vest. The fair value of equity awards is charged to the statement of operations over the service period. The offset to the recorded cost is to additional Paid in Capital. Consideration received on the exercise of stock options is recorded as capital stock and the related share-based payments reserve is transferred to share capital. n. Contingencies The Company is involved in various commercial and other legal proceedings that arise from time to time in the ordinary course of business. Except for income tax contingencies or contingent consideration or other contingent liabilities incurred or acquired in a business combination, the Company records accruals for these types of contingencies to the extent that Company concludes their occurrence is probable and that the related liabilities are reasonably estimated. When accruing these costs, the Company will recognize an accrual in the amount within a range of loss that is the best estimate within the range. When no amount within the range is a better estimate than any other amount, the Company accrues for the minimum amount within the range. Legal costs are expensed as incurred. Contingent consideration and other contingent liabilities incurred or acquired in a business combination are recorded at a probability weighted assessment of their fair value and monitored on an ongoing basis for changes in that value. o. Newly issued accounting pronouncements In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes the revenue recognition requirements in Accounting Standards Codification (“ASC”) 605, Revenue Recognition. The new revenue recognition standard requires entities to recognize revenue in a way that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. In August 2015, the FASB issued Accounting Standards Update No. 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date, or ASU 2015-14. This amendment defers the effective date of the previously issued Accounting Standards Update ASU 2014-09, until the interim and annual reporting periods beginning after December 15, 2017. Earlier application is permitted for interim and annual reporting periods beginning after December 15, 2016. In August 2015, the FASB has issued Accounting Standards Update (ASU) No. 2015-15, Interest - Imputation of Interest (Subtopic 835-30): Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements - Amendments to SEC Paragraphs Pursuant to Staff Announcement at June 18, 2015 EITF Meeting . This ASU adds SEC paragraphs pursuant to the SEC Staff Announcement at the June 18, 2015, Emerging Issues Task Force meeting about the presentation and subsequent measurement of debt issuance costs associated with line-of-credit arrangements. Given the absence of authoritative guidance within ASU 2015-03 for debt issuance costs related to line-of-credit arrangements, the SEC staff would not object to an entity deferring and presenting debt issuance costs as an asset and subsequently amortizing the deferred debt issuance costs ratably over the term of the line-of-credit arrangement, regardless of whether there are any outstanding borrowings on the line-of-credit arrangement. The Company does not expect this update will have a material impact on the presentation of the Company’s consolidated financial position, results of operations and cash flows. In November 2015, the FASB has issued Accounting Standards Update (ASU) No. 2015-17, Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes, which changes how deferred taxes are classified on organizations’ balance sheets. The ASU eliminates the current requirement for organizations to present deferred tax liabilities and assets as current and noncurrent in a classified balance sheet. Instead, organizations will be required to classify all deferred tax assets and liabilities as noncurrent. The amendments apply to all organizations that present a classified balance sheet. For public companies, the amendments are effective for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods. The Company does not expect this update will have a material impact on the presentation of the Company’s consolidated financial position, results of operations and cash flows.

FAIR VALUE MEASUREMENT

FAIR VALUE MEASUREMENT	12 Months Ended
	Dec. 31, 2016
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENT	NOTE 3 - FAIR VALUE MEASUREMENT The Company’s financial assets and liabilities that are measured at fair value on a recurring basis by level within the fair value hierarchy are as follows (in thousands): As of December 31, 2016 Level 1 Level 2 Level 3 Total Liabilities: Obligation to issue shares of Common Stock $ 187 $ — $ — $ 187 Deferred payment due to the acquisition of the SPVs $ — $ — $ 2,685 $ 2,685 Warrants Liability $ — $ — $ 2,045 $ 2,045 Total liabilities $ 187 $ — $ 4,730 $ 4,917 Balance as of December 31, 2015, Level 1 Level 2 Level 3 Total Liabilities: Deferred payment due to the acquisition of the SPVs $ — $ — $ 2,910 $ 2,910 Warrants liability $ — $ — $ 544 $ 544 Total liabilities $ — $ — $ 3,454 $ 3,454 Deferred payment due to the acquisition of the SPVs - Represents the remaining balance of fifty percent (50%) of the Purchase Price that is due to the Sellers on the third anniversary of the closing date. The fair value measurement of the fair market value of the Deferred Payment is based on significant inputs not observed in the market and thus represents a Level 3 measurement, which reflects the Company’s own assumptions in measuring fair value. The Company estimated the fair value of the Deferred Payment using the discounted cash flow model. Key assumptions include the level and timing of the expected future payment and discount rate consistent with the level of risk and economy in general. The Deferred payment due to the acquisition of the SPVs is included in long term loans and Liabilities in the consolidated Balance Sheets and the change in fair value of remaining balance is included in interest expenses in the consolidated statements of income. Deferred payment due to the acquisition of the SPVs Balance at January 1, 2015 $ — Increase due to acquisition of the SPVs 2,910 Balance at December 31, 2015 $ 2,910 Changes in fair value, interest expense and translation adjustments (225) Balance at December 31, 2016 $ 2,685 Warrant Liability—The estimated fair values of outstanding warrant liability were measured using Black-Scholes valuation models. These valuation models involved using such inputs as the estimated fair value of the underlying stock at the measurement date, risk-free interest rates, expected dividends on stock and expected volatility of the price of the underlying stock. Due to the nature of these inputs, the valuation of the warrants was considered a Level 3 measurement. As of December 31,2016, and 2015, the Level 3 liabilities consisted of the Company’s warrant liability. Warrants Liability Balance at January 1, 2015 $ — Issuance of warrants 325 Changes in fair value 219 Balance at December 31, 2015 $ 544 Issuance of warrants 2,839 Changes in fair value 1,338 Balance at December 31, 2016 $ 2,045

INVESTMENTS IN NONCONSOLIDATED

INVESTMENTS IN NONCONSOLIDATED AFFILIATES	12 Months Ended
	Dec. 31, 2016
Investments in and Advances to Affiliates, Schedule of Investments [Abstract]
INVESTMENTS IN NONCONSOLIDATED AFFILIATES	NOTE 4 – INVESTMENTS IN NONCONSOLIDATED AFFILIATES Investment in nonconsolidated affiliates consists of the following: December 31, 2016 December 31, 2015 Carrying Value (In thousands) Ownership Percentage Carrying Value (In thousands) Ownership Percentage Investment in Concord Energy Partners, LLC $ 5,960 25.00 % $ 4,795 25.00 % Rhode Island Energy Partners LLC $ 4,177 22.75 % $ 2,775 22.75 % Total $ 10,137 $ 7,570 Deferred revenues from nonconsolidated affiliates consists of the following: December 31, 2016 December 31, 2015 Carrying Value (In thousands) Ownership Percentage Carrying Value (In thousands) Ownership Percentage Deferred revenues from Concord Energy Partners, LLC $ — 25.00 % $ 4,795 25.00 % Deferred revenues from Rhode Island Energy Partners LLC $ 4,177 22.75 % $ 2,776 22.75 % Deferred Revenue from Services from Rhode Island Energy Partners LLC $ 1,481 22.75 % $ 1,481 22.75 % Total $ 5,658 $ 9,052 Deferred revenues represent payment that were received by the Company in connection of those projects but were not recognized as revenue and increase in the affiliate’s membership interest accounted by the Company using the step-by-step basis in accordance with ASC 323-10-35-15. Such deferred revenues will be recorded to the Income statement upon the commencement of the commercial operations of the plant and fulfillment of all the Company’s obligation under the above agreements. North Carolina Project On January 30, 2015, the Company, Concord Energy Partners, LLC (“Concord”) and York Renewable Energy Partners LLC (“York”) entered a development and indemnification agreement (the “Concord Development and Indemnification Agreement”), pursuant to which the Company will own 25% of the membership interest of Concord and York will pay the Company $1,250 in consideration of the Company’s Project Development Services. York also agreed to pay the Company two equal installments of $587 upon the commencement of the commercial operation and mechanical completion of the North Carolina project. The Company’s right to receive distributions from Concord are subject to certain priorities in favor of York, as follows: (a) The unpaid rate of return, equal to nine percent (9%) per annum and compounded annually, of unrecovered capital contributions outstanding, will be paid to York; (b) The unpaid and unrecovered capital contributions outstanding will be paid to York; (c) The amount of any excess profits from “feedstock tipping fees” shall be distributed with twenty percent (20%) will be paid to York, and the balance to the Company; (d) The amount of any excess profits from “thermal energy” shall be distributed equally between the Company and York; and (e) Any amount remaining will be distributed pro-rata In addition, the Company’s right to receive distributions upon a liquidation event of Concord are subject to certain priorities in favor of York, as follows: (a) The unpaid rate of return, equal to nine percent (9%) per annum and compounded annually, of unrecovered capital contributions outstanding, will be paid to York; (b) The unpaid and unrecovered capital contributions outstanding will be paid to York; and (c) Any amount remaining will be distributed pro-rata On November 18, 2016, The North Carolina Project commenced commercial operations and started to provide its output to Duke Energy pursuant to the Purchase Power Agreement with Duke. The commencement of the commercial operations includes the gradual intake of waste from the Facility’s feedstock suppliers, increasing the parasitic load to the digesters, completing the waste-water-treatment resources and completing all other mechanical features needed for the Facility to operate at full capacity. The Company estimates that construction of the facility will be fully completed by March 31, 2017. Rhode Island Project On April 8, 2015, the Company, Rhode Island Energy Partners LLC (“Rhode Island”) and York entered into a development and indemnification agreement (the “Rhode Island Development and Indemnification Agreement”), pursuant to which the Company will own 22.75% of the membership interest of Rhode Island and York will pay the Company $1,482 in consideration of the Company’s Project Development Services. Pursuant to this agreement York also agreed to pay the Company three equal installments of $563 upon the signing of the Rhode Island Development and Indemnification Agreement, the commencement of the commercial operation and mechanical completion of the Rhode Island project. The company’s right to receive distributions from Rhode Island are subject to certain priorities in favor of York, as follows: (a) The amount of any excess profits from “feedstock tipping fees” shall be distributed with twenty percent (20%) going to York, and eighty percent (80%) going to us; (b) The amount of any excess profits from “thermal energy” shall be distributed equally between the Company and York; and (c) Any amount remaining will be distributed pro-rata Rhode Island project. The company’s right to receive distributions upon a liquidation event of Concord are subject to certain priorities in favor of York, as follows: (a) The unpaid guaranteed obligation return will be paid to York; (b) The unpaid rate of return, equal to nine percent (9%) per annum and compounded annually, of unrecovered capital contributions outstanding, will be paid to York; (c) The unpaid and unrecovered capital contributions outstanding will be paid to York; and (d) Any amount remaining will be distributed pro-rata Rhode Island project. On January 13, 2017, the Company and Orbit Energy, Inc., a former partner of the Company in both projects entered into an agreement to reduce certain of the Company’s past obligations in consideration of Two Hundred Thousand Dollars ($200) which will be paid in twelve monthly equal installments starting January 27, 2017. Any amount not paid when due will accrue interest at the simple annual rate of eight per cent (8%) from the date due until the date fully paid. The Company accrued the full settlement amount at December 31, 2016. The tables set forth below summarize the combined financial information related to the nonconsolidated affiliates that are accounted for under the equity method as of December 31, 2016, and December 31,2015. December 31, 2016 (Dollars in thousands) Concord Rhode Island Assets: Restricted Cash $ 500 $ 751 Property, Plant and Equipment, net of accumulated depreciation 26,169 19,230 Total assets $ 26,669 $ 19,981 Current liabilities $ 652 $ 142 Membership Interest 26,017 19,839 Total liabilities and Membership Interest $ 26,669 $ 19,981 December 31, 2015 (Dollars in thousands) Concord Rhode Island Assets: Property, Plant and Equipment, net of accumulated depreciation $ 22,878 15,901 Other assets 17 — Total assets $ 22,895 $ 15,901 Current liabilities $ 2,127 $ 2,224 Membership Interest 20,768 13,677 Total liabilities and Membership Interest $ 22,895 $ 15,901

INVESTMENTS IN NONCONSOLIDATE12

INVESTMENTS IN NONCONSOLIDATED SUBSIDIARIES	12 Months Ended
	Dec. 31, 2016
Equity Method Investments and Joint Ventures [Abstract]
INVESTMENTS IN NONCONSOLIDATED SUBSIDIARIES	NOTE 5 – INVESTMENTS IN NONCONSOLIDATED SUBSIDAIRIES In 2015, The Company acquired one hundred percent (100%) of the share capital of Agricerere S.r.l., Agrielektra S.r.l., Agrisorse S.r.l. and Gefa S.r.l (each, an “SVP” and collectively, the “SVPs”) in consideration of $5,647 (€5,200) (“Purchase Price”). Each SVP owns and operates an anaerobic digestion biogas plant for the production and sale of electricity to Gestore del Servizi Energetici GSE, S.p.A., a state-owned utility company, pursuant to a power purchase agreement. The Company to paid 50% of the Purchase Price on the closing date (December 14, 2015) and the remaining balance will be paid on the third anniversary of the closing date. The remaining balance bears interest at an annual rate of two percent (2%). The Purchase Price is subject to certain adjustments and to the difference between the actual EBITDA results in the 18 months following the closing date divided by 1.5 and € 935, per the following mechanism: (i) If the actual EBITDA results in the 18 months following the closing date divided by 1.5 is greater than € 935 then the deferred payment shall be increased by the amount equal to 50% (fifty per cent) of this difference. (ii) If the actual EBITDA results in the 18 months following the closing date divided by 1.5 is lesser than € 935 then the deferred payment shall be reduced by the amount of the amount necessary to maintain Purchase Price that yields an Equity IRR of 25%, but not more than 35% of the remaining balance. The Company also agreed to reimburse the sellers the VAT amount that was claimed by the SPVs through the closing date. The reimbursed amount will not exceed € 1,160 and will be refunded to the Sellers only after the amount will be refunded to the Company by the VAT authorities in Italy. In 2015, the Company entered into an EBITDA Guarantee Agreement (“EBITDA Guarantee Agreement”) with Austep S.p.A. (“Austep”). Austep specializes in design, construction, operation and servicing of anaerobic digestion plants. Pursuant to the EBITDA Guarantee Agreement, Austep will operate, maintain and supervise the Company’s biogas plants in consideration to a monthly guaranteed EBITDA of $204 (€188) during the initial six months following the Closing Date and an annual guaranteed EBITDA of $4,083 (€3,760) then after. Pursuant to the terms of the agreements with Austep, the Company will receive the guaranteed levels of EBITDA and Austep will receive ninety percent (90%) of the revenue in excess of these levels. The Company applies the equity method because the EBITDA Guarantee Agreement whereby Austep operates, maintains and supervises each plant, prevents the Company from exercising a controlling influence over operating policies of the plants. Under this method, the equity investment is reflected as an investment in non-consolidated subsidiaries on our Balance Sheets and the net earnings or losses of the investments is reflected as equity in net earnings of nonconsolidated subsidiaries on the Company’s consolidated statements of operations. The Company’s investment in the SPV’s carrying value exceeded its proportionate share of the net assets of the SPVs by $19. This Premium was recognized as part of the carrying value in the Company’s equity investment in the SPVs. Investment in nonconsolidated subsidiaries included the following activity during the years: Year ended December 31, 2016 2015 Balance at beginning of period $ 4,993 $ — Investment in nonconsolidated subsidiaries — 5,031 Equity in losses of nonconsolidated subsidiaries (444 ) (38 ) Translation adjustment (120 ) — Balance at end of period $ 4,429 $ 4,993 The table set forth below summarize the combined financial information related to our nonconsolidated subsidiaries that are accounted for under the equity method as of December 31, 2016, and December 31, 2015. (Dollars in thousands) December 31, 2016 December 31, 2015 Assets: Current Assets $ 2,735 $ 2,753 Property, Plant and Equipment, net of accumulated depreciation 16,167 18,109 Other Non-Current Assets 7,970 6,054 Total assets $ 26,872 $ 26,916 Liabilities and Shareholder’s Deficit: Current liabilities $ 8,221 $ 4,697 Long Term Liabilities 14,282 17,286 Total liabilities 22,503 21,983 Shareholder’s Equity 4,369 4,933 Total Shareholder’s Equity 4,369 4,933 Total liabilities and Shareholder’s Equity $ 26,872 $ 26,916

CURRENT MATURITIES OF DEBENTURE

CURRENT MATURITIES OF DEBENTURES AND LONG TERM LOANS	12 Months Ended
	Dec. 31, 2016
Debt Disclosure [Abstract]
CURRENT MATURITIES OF DEBENTURES AND LONG TERM LOANS	NOTE 6 – CURRENT MATURITIES OF DEBENTURES AND LONG TERM LOANS Current Maturities of Debentures and Long Term Loans consisted of the following: Interest rate as of December 31, 2016 December 31, 2016 December 31, 2015 Debentures 11% $ 2,658 $ — Current Maturities portion of Loan from Helios 14.5% 289 517 Current Maturities Long Term Loan from Bank 1.8-6% 41 32 Total Current Maturities of Debentures and Long Term Loans $ 2,988 $ 549

SHORT TERM LOAN

SHORT TERM LOAN	12 Months Ended
	Dec. 31, 2016
Debt Disclosure [Abstract]
SHORT TERM LOAN	NOTE 7 – SHORT TERM LOAN On October 25, 2016, the Company completed a private placement of its securities (the “October Financing”) to an accredited investor. Pursuant to the October Financing, the Company agreed to issue to the Investor shares of the Company’s common stock, notes and warrants, in exchange for up to $1,000 in accordance with the following payment schedule: $500 paid at closing, $250 in guaranteed financing upon the achievement of certain milestones, and up to an additional $250 in financing upon the mutual agreement of the Investor and the Company. The balance as of December 31, 2016, represents a six (6) month promissory note in the amount of $750, accrued interest in the amount of $39 less the unamortized amount of fair value of the issued warrants using the Black-Scholes in the amount of $322 and a balance of $188 that represents the Company’s obligation to issue shares of Common Stock equal to twenty-five percent (25%) of the Note Principal to the Investor. Per the SPA the Company may exercise its right to repay the Note at any time on or before its maturity date. The Note is convertible into shares of the Common Stock only upon default event as set forth in the agreement of repayment at a price per share equal to the lesser of (i) USD $0.075, or (ii) a sixty percent (60%) discount to the lowest trade price in the twenty five (25) trading days prior to the conversion.

ACCRUED SEVERANCE PAY

ACCRUED SEVERANCE PAY	12 Months Ended
	Dec. 31, 2016
Compensation Related Costs [Abstract]
ACCRUED SEVERANCE PAY	NOTE 8 – ACCRUED SEVERANCE PAY The Israeli labor laws generally require severance payments upon dismissal of an employee or upon termination of employment in certain other circumstances. The following principal plans relate to the Company’s employees in Israel: Severance pay liability with respect to Israeli employees’ is calculated pursuant to Israeli Severance Pay Law based on the most recent salary of the employees multiplied by the number of years of employment as of the balance sheet date. The Company records an expense for the increase in its severance liability, net of earnings (losses) from the related severance pay fund. The liability is presented on the undiscounted basis as a long-term liability. Severance pay expenses were $24 thousand and $2 thousand for the years ended December 31, 2016 and September 30, 2015, respectively. Severance pay expenses were $1 thousand for the three months’ period ended December 31, 2015, respectively. The Company’s liability for its Israeli employees is covered for by monthly deposits with severance pay funds. The value of the deposited funds is based on the cash surrender value of these policies and includes profits (or loss) accumulated through the balance sheet date. The deposited funds may be withdrawn only upon the fulfillment of the obligations pursuant to Israeli Severance Pay Law or labor agreements.

LONG TERM LOANS AND LIABILITIES

LONG TERM LOANS AND LIABILITIES	12 Months Ended
	Dec. 31, 2016
Debt Disclosure [Abstract]
LONG TERM LOANS AND LIABILITIES	NOTE 9 – LONG TERM LOANS AND LIABILITIES Long-term loans and liabilities consisted of the following: Interest rate as of December 31, 2016 December 31, 2016 December 31, 2015 Deferred payment due to the acquisition of the SPVs (1) 2% $ 2,685 $ 2,910 Long Term portion of Loan from Helios (2) 14.5% 2,607 3,149 Total current assets $ 5,292 $ 6,059 Less: current maturities of Long Term portion of Loan from Helios (2) 14.5% 289 516 $ 5,003 $ 5,543 (1) Represents the remaining balance of fifty percent (50%) of the Purchase Price that is due to the Sellers on the third anniversary of the closing date. This amount will be adjusted to the variation of EBITDA as described above and is promised by a note to each Seller, to be paid on the third anniversary of the closing, along with interest on the unpaid balance due at an annual rate of two percent (2%). The fair value measurement of the fair market value of the remaining balance is based on significant inputs not observed in the market and thus represents a Level 3 measurement, which reflects the Company’s own assumptions in measuring fair value. The Company estimated the fair value of the remaining balance using the discounted cash flow model. Key assumptions include the level and timing of the expected future payment and discount rate consistent with the level of risk and economy in general. The balance of the Deferred payment due to the acquisition of the SPVs is included in long term loans and Liabilities in the consolidated Balance Sheets and the change in fair value of remaining balance is included in interest expenses in the consolidated statements of income. (2) In 2015, the Company entered into a Long Term Mezzanine Loan Agreement (the “Helios Loan Agreement”) with Helios Italy Bio-Gas 1 L.P. (“Helios”) to finance the acquisition of the SPVs. Under the Helios Loan Agreement, the Company borrowed €2,900,000 ($3,149,000) at annual interest rate of fourteen and one-half percent (14.5%), paid quarterly. Helios is also entitled to an annual operation fee of one and one-half percent (1.5%), paid quarterly. The final payment of the loan will become due no later than the earlier of (a) thirteen and one half years from the date such loan was made available to the Company, and (b) the date that the Feed in Tariff license granted to the relevant SVP expires. Pursuant to the Helios Loan Agreement, the Company pledged all its shares in Eastern and Bluesphere Pavia to secure the outstanding balance under the Helios Loan Agreement.

DEBENTURES

DEBENTURES	12 Months Ended
	Dec. 31, 2016
Debt Disclosure [Abstract]
DEBENTURES	NOTE 10 – DEBENTURES Beginning in November 2015, the Company conducted an offering of up to $3,000 of the Company’s Senior Debentures and warrants to purchase up to 8,000,000 shares of Common Stock, in proportion pro rata to each Subscriber’s subscription amount relative to the total offering amount, with 50% of the Debenture Offering Warrants exercisable at a price per share of $0.05 and the other 50% of the Debenture Offering Warrants exercisable at price per share of $0.075. The Debenture Offering Securities were offered pursuant to subscription agreements with each investor (the “Debenture Offering Subscription Agreement”). Pursuant to the Debenture Offering Subscription Agreements, the investors in the Debenture Offering shall have the right to collectively designate one observer or member to the Company’s Board of Directors. On December 23, 2015, the Company completed the Debenture Offering and entered into Debenture Offering Subscription Agreements with investors representing aggregate gross proceeds to the Company of $3,000. During the year ended December 31, 2016, the Company recorded amortization expenses in the amounts of $298, in respect of the discounts recorded on the debentures. During the year ended December 31, 2015, the Company recorded amortization expenses in the amounts of $11, in respect of the discounts recorded on the debentures.

WARRANTS LIABILITY

WARRANTS LIABILITY	12 Months Ended
	Dec. 31, 2016
Warrants Liability
WARRANTS LIABILITY	NOTE 11 – WARRANTS LIABILITY At each balance sheet date, the Company had the following warrants to purchase common stock outstanding: Fair value Fair value Warrants of Warrants Warrants of Warrants outstanding Liabilities as of outstanding Liabilities as of as of December 31, 2016 as of December 31, 2015 December 31, 2016 (in thousands) December 31, 2015 (in thousands) May 1, 2014 Warrants ($0.10 per share) 1,500,000 $ 26 1,500,000 $ — November 2015 Warrants ($0.05 per share) (1) 4,000,000 155 4,000,000 175 November 2015 Warrants ($0.075 per share) (1) 4,000,000 128 4,000,000 174 November 2015 Warrants ($0.06875 per share) (1) 4,480,000 150 4,480,000 195 February 3, 2016 Warrants ($0.06 per share) (2) 1,500,000 42 — — February 2016 Offering ($0.10 per share) (3) 17,500,000 485 — — February 2016 Offering ($0.061 per share) (3) 2,800,000 101 — — February 2016 Offering ($0.11 per share) (3) 1,400,000 36 — — July 2016 Offering ($0.11 per share) (4) 18,266,668 512 — — July 2016 Offering ($0.121 per share) (4) 928,000 25 — — July 2016 Offering ($0.083 per share) (4) 928,000 30 — — October 2016 Offering ($0.075 per shares) (5) 10,000,000 353 — — Total 67,302,668 $ 2,045 13,980,000 $ 544 Average date to maturity (in years) 4.25 4.78 Average exercise price $ 0.0901 $ 0.06825 (1) Pursuant to the November 2015 Offering, the Company sold warrants to purchase up to 4,000,000 shares of Common Stock at an exercise price per share of $0.05 and warrants to purchase up to 4,000,000 shares of Common Stock at an exercise price per share of $0.075. The Warrants are exercisable until December 22, 2020 and were accounted for as derivative liabilities. The Company has estimated the fair value of such warrants at a value of $209 at the date of issuance using the Black-Scholes option pricing model using the following assumptions: % Dividend yield 0 % Risk-free interest rate 1.74 % Expected term (years) 5 Volatility 202 % The Company engaged Maxim Group LLC (“Maxim”) to assist in the Debenture Offering. Pursuant to the terms of the engagement Maxim received warrants to purchase 4,480,000 shares of Common Stock at an exercise price of $0.06875 per share. The Warrants are exercisable until December 22, 2020 and were accounted for as derivative liabilities. The Company has estimated the fair value of such warrants at a value of $117 at the date of issuance using the Black-Scholes option pricing model using the following assumptions: % Dividend yield 0 % Risk-free interest rate 1.74 % Expected term (years) 5 Volatility 202 % (2) On February 3, 2016, the Company issued warrants to purchase up to 1,500,000 shares of our common stock of the Company at an exercise price of $0.06 per share, in full satisfaction of certain obligations of the Company. The Warrants are exercisable until February 2, 2019 and were accounted for as derivative liabilities. The Company has estimated the fair value of such warrants at a value of $87 at the date of issuance using the Black-Scholes option pricing model using the following assumptions: % Dividend yield 0 % Risk-free interest rate 1.20 % Expected term (years) 3 Volatility 203 % (3) Pursuant to the February 2016 Offering, the Company sold warrants to purchase up to 17,500,000 shares of Common Stock at an exercise price per share of $0.10. The Warrants are exercisable until February 14, 2021 and were accounted for as derivative liabilities. The Company has estimated the fair value of such warrants at a value of $847 at the date of issuance using the Black-Scholes option pricing model using the following assumptions: % Dividend yield 0 % Risk-free interest rate 1.20 % Expected term (years) 5 Volatility 203 % The Company engaged Maxim Group LLC to assist in the February 2016 Offering. Pursuant to the terms of the engagement Maxim received warrants to purchase 2,800,000 shares of Common Stock at an exercise price of $0.0605 per share and warrants to purchase 1,400,000 shares of Common Stock at an exercise price of $0.11 per share. The Warrants are exercisable until February 14, 2021 and were accounted for as derivative liabilities. The Company has estimated the fair value of such warrants at a value of $204 at the date of issuance using the Black-Scholes option pricing model using the following assumptions: % Dividend yield 0 Risk-free interest rate 1.20 % Expected term (years) 5 Volatility 203 % (4) Pursuant to the July 2016 Offering, the Company sold warrants to purchase up to 18,266,668 shares of Common Stock at an exercise price per share of $0.11. The Warrants are exercisable until July 25, 2021 and were accounted for as derivative liabilities. The Company has estimated the fair value of such warrants at a value of $1,140 at the date of issuance using the Black-Scholes option pricing model using the following assumptions: % Dividend yield 0 % Risk-free interest rate 1.00 % Expected term (years) 5 Volatility 147 % The Company engaged Maxim Group LLC to assist in the July 2016 Offering. Pursuant to the terms of the engagement Maxim received warrants to purchase 928,001 shares of Common Stock at an exercise price of $0.083 per share and warrants to purchase 928,001 shares of Common Stock at an exercise price of $0.121 per share. The Warrants are exercisable until July 25, 2021 and were accounted for as derivative liabilities. The Company has estimated the fair value of such warrants at a value of $117 at the date of issuance using the Black-Scholes option pricing model using the following assumptions: % Dividend yield 0 Risk-free interest rate 1.00 % Expected term (years) 5 Volatility 147 % (5) Pursuant to the October 2016 Offering, the Company sold warrants to purchase up to 10,000,000 shares of Common Stock at an exercise price per share of $0.075. 6,666,666 Warrants are exercisable until October 24, 2021 and the balance are exercisable until December 19, 2021. The warrants were accounted for as derivative liabilities. The Company has estimated the fair value of such warrants at a value of $504 at the date of issuances using the Black-Scholes option pricing model using the following assumptions: % Dividend yield 0 % Risk-free interest rate 1.75-2.04 % Expected term (years) 5 Volatility 77-89 %

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	12 Months Ended
	Dec. 31, 2016
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 12 – RELATED PARTY TRANSACTIONS On December 18, 2015, The Company entered into a no-interest bearing $129 promissory note with R.S. Palas Management Ltd., an entity owned and controlled by Shlomo Palas. The loan under the promissory note was used to finance a portion of the acquisition of the four SPVs in Italy pursuant to the Italy Projects Agreement. The Company paid back the loan under the promissory note with proceeds from the debentures offering that was completed in December, 2015. In July 2015, in order to finance a portion of the funds necessary to complete the acquisitions of the SPVs by Bluesphere Pavia, we conducted a private placement of up to $250 of our Common Stock at $0.0176 per share to certain accredited investors. On December 2, 2015, we closed on the July Offering, resulting in gross proceeds to the Company of $225 and agreed to issue 21,588,871 shares of our Common Stock at $0.0104 per share, pursuant to certain subscription agreements. All investors in the July Offering were accredited investors and independent of the Company, but were part of a group led by a former member of our Board, Itai Haboucha. Mr. Haboucha did not receive any shares of Common Stock, was not paid any commissions and received no other compensation in connection with the July Offering. On June 2, 2016 the Company issued 13,930,742 shares of Common Stock in consideration of $146. On December 14, 2016 the Company issued 7,658,129 shares of Common Stock in consideration of $84.

CONTINGENT AND COMMITMENTS

CONTINGENT AND COMMITMENTS	12 Months Ended
	Dec. 31, 2016
Commitments and Contingencies Disclosure [Abstract]
CONTINGENT AND COMMITMENTS	NOTE 13 – CONTINGENT AND COMMITMENTS From time to time the Company may be a party to commercial and litigation matters involving claims against the Company. None of the Company’s directors, officers, nonconsolidated affiliates, or any owner of record or beneficially of more than five percent of the Company’s Common Stock, is involved in a material proceeding adverse to the Company and its subsidiaries or has a material interest adverse to the Company or its subsidiaries. The Company accrues a liability for such matters when it is probable that future expenditures will be made and such expenditures can be reasonably estimated. In management’s opinion, there are no current matters that would have a material effect on the Company’s financial position or results of operations and no contingent liabilities requiring accrual as of December 31, 2016. On October 22, 2016, the law firm of JS Barkats PLLC filed a complaint against the Company and its Chief Executive Officer, seeking allegedly unpaid legal fees for services rendered from June 9, 2011 through April 23, 2012 in the amount of $428 thousands, plus interest for a total of $652 thousands. This Litigation was filed as JS Barkats PLLC v. Blue Sphere Corporation and Shlomo Palas with the Supreme Court of the State of New York for the County of New York , Index No. 655600/2016. On October 26, 2016, without notice to the Company or its Chief Executive Officer or an opportunity to be heard, the New York Court issued a Temporary Restraining Order (the “TRO”) in favor JS Barkats PLLC, prohibiting the Company and Mr. Palas from transferring or dissipating any assets up to $652. On October 31, 2016, the Company removed the Barkats Litigation to federal court, filed as JS Barkats PLLC v. Blue Sphere Corporation and Shlomo Palas with the United Stated District Court, Southern District Court of New York, Docket No. 1:16-cv-08404, and on December 6, 2016, Mr. Barkats filed a motion to remand to the New York Court and request for oral argument. The Company terminated the services of JS Barkats LLC in 2012 and management believe the claims brought by JS Barkats PLLC are without merit, that the TRO was improvidently granted, and that JS Barkats PLLC misrepresented, mischaracterized and omitted material facts and the law in seeking the TRO. The Company intend to vigorously defend against this Litigation, the TRO and any other attempts to attach the assets of the Company.

COMMON SHARES

COMMON SHARES	12 Months Ended
	Dec. 31, 2016
Stockholders' Equity Note [Abstract]
COMMON SHARES	NOTE 14 – COMMON SHARES Common Stock Reserved for Future Issuance The Company had shares of common stock reserved for issuance as follows: Year ended December 31, 2016 2015 Outstanding warrants to purchase common stock 67,302,668 13,980,000 Outstanding Options to purchase common stock 778,761 778,761 Approved but not Outstanding Options to purchase common stock — 3,175,000 Unvested Common Stock under the 2014 Incentive Plan 962,500 7,316,667 Common Stock reserved under the 2016 Incentive Plan 30,000,000 — Option to purchase Common Stock reserved under the 2016 Incentive Plan 15,000,000 — Common Stock reserved under the October 2016 Offering 57,000,000 — Total shares reserved for issuance 171,043,929 25,250,428 Issuances On October 28, 2014, the Company issued 335,000 shares of the Company’s common stock, in connection with the May 1, 2014 service agreement. During October, 2014, an investor converted $42 principal amount out of the April 11, 2014 notes for 471,967 shares of the Company’s common stock. On December 8, 2014, the Company issued 209 shares of the Company’s common stock to Carter Terry. On October 3, 2014, the Company signed a consulting agreement with a consultant according to which the consultant would provide investor relation and public relations services for a period of one year. The Company agreed to grant the consultant 2,000,000 shares of the Company and additional 500,000 options to purchase Company’s shares at an exercise price of $0.001 per shares. Such shares were issued on March 19, 2015. In addition, on the same date the Company issued the consultant 500,000 shares of the Company for the exercised of the options granted. The Company has estimated the fair value of such shares and options, and recorded an expense of $217. On January 5, 2015, the Company signed a consulting agreement with Dr. Borenstein Ltd according to which the company issued the consultant 1,000,000 options to purchase 1,000,000 shares of common stock of the Company at an exercise price of $0.001 for one year commencing the date of the agreement. The Consultant exercised such options at May 27, 2015. The Company has estimated the fair value of such options, and recorded an expense of $158. On February 28, 2015 and March 19, 2015, the Company issued 6,114,867 shares of the Company to a consultant in respect of his September 2014 consulting investor relation and public relations services agreement with the Company. The Company has estimated the fair value of such shares, and recorded an expense of $738. On March 12, 2015, the Company issued 109,039 shares of the Company for an investor pursuant to the exercise of his options granted at May 2014. The Company has estimated the fair value of such shares, and recorded an expense of $14. In May and June 2015, the Company issued 3,765,000 shares of the Company to a consultant in respect of his investor relations and public relations services pursuant to a consulting agreement with the Company. The Company has estimated the fair value of such shares, and recorded an expense of $150. In May 2015, the Company issued 3,250,000 shares of the Company to a consultant in respect of his investor relations and public relations services pursuant to a consulting agreement with the Company. The Company has estimated the fair value of such shares, and recorded an expense of $136. On June 15, 2015 the Company issued consultant 1,500,000 shares of common stock of the Company in mutual agreement for termination of his June 2014 consulting agreement. The Company has estimated the fair value of such shares, and recorded an expense of $34. From July through September 2015, the Company issued 8,035,000 shares of common stock to a consultant in respect of his investor relations and public relations services consulting agreement with the Company. The Company has estimated the fair value of such shares, and recorded an expense of $199. In August 2015, the Company issued 3,474,405 shares of the Company to Maxim Group LLC in respect of its financial advisor and investment banker agreement with the Company. The shares have been valued and recorded at $34. In August 2015, the Company issued 1,128,237 shares of the Company to a non-U.S. person in respect of its financial advisor and investment banker settlement agreement with the Company. The Company has estimated the fair value of such shares, and recorded an expense of $13. On April 13, 2015, the Company entered into a subscription agreement with a non-U.S. person pursuant to which the Company issued 416,667 shares of common stock in exchange for $25. On April 15, 2015, the Company entered into a Subscription Agreement with Dr. Borenstein Ltd. (the “April Borenstein Subscription Agreement”) pursuant to which the Company agreed to sell 1,630,000 shares of common stock of the Company for the aggregate purchase price of $48. On June 12, 2015, the Company entered into a Subscription Agreement with Dr. Borenstein Ltd. (the “June Borenstein Subscription Agreement”) pursuant to which the Company agreed to sell 8,484,848 shares of common stock of the Company for the aggregate purchase price of $140. On July 1, 2015, the Company entered into a subscription agreement with a non-U.S. person pursuant to which the Company issued 2,000,000 shares of common stock in exchange for $32. On July 6, 2015, the Company entered into a subscription agreement with several non-U.S. entity pursuant to which the Company issued 2,428,571 shares of common stock in exchange for $51. On July 17, 2015, the Company entered into a subscription agreement with several non-U.S. personnel pursuant to which the Company issued 2,318,183 shares of common stock in exchange for $39. From February through August 2015, convertible promissory notes holders representing an aggregate principal amount of $1,480,716 converted their notes into 75,060,414 shares of the Company’s common stock. On January 26, 2016, the Company issued 1,000,000 shares of Common Stock, pursuant to a subscription agreement dated June 12, 2015. On February 1, 2016, the Company issued 540,000 shares Common Stock to a consultant in respect of his consulting services for the Company. The Company has estimated the fair value of such shares, and recorded an expense of $108. In February 2016, the Company conducted an offering (the “February 2016 Offering”) consisting of (a) up to $1,925 of the Company’s shares of Common Stock, priced at the closing price for shares of Common Stock, as reported on the OTCQB Venture Marketplace, on the trading day prior to the closing of the February Offering, and (b) 5-year warrants to purchase shares of Common Stock in an amount equal to 50% of the number of shares of Common Stock so purchased by the. The Securities have been offered pursuant to subscription agreements with each investor. In addition to other customary provisions, each Subscription Agreement provides that the Company will use its reasonable commercial efforts to register all shares of Common Stock sold in the February Offering, including all shares of Common Stock underlying the February Warrants, within 60 days of the closing of the February Offering. The February Warrants are exercisable for 5 years from the date of issuance at $0.10 per share, include an option by which the holder may exercise the Warrant by means of a cashless exercise, and include customary weighted-average price adjustment and anti-dilution terms. On February 15, 2016, the Company completed the only closing of the February Offering, representing aggregate gross proceeds to the Company of $1,925. In connection with the closing, the Company and subscribers entered into (a) February Subscription Agreements for, in the aggregate, 35,000,000 shares of Common Stock at $0.055 per share, and (b) February Warrants to purchase, in the aggregate, up to 17,500,000 shares of Common Stock at an exercise price of $0.10 per share. The Company engaged Maxim to assist in the February 2016 Offering. Pursuant to the terms of an engagement letter between Maxim and the Company, Maxim received commissions equal to 7% of the gross proceeds raised by Maxim in the February Offering, warrants to purchase, in the aggregate, up to 2,800,000 shares of Common Stock at an exercise price of $0.0605 per share and to purchase, in the aggregate, up to 1,400,000 shares of Common Stock at an exercise price of $0.11 per share. On March 15, 2016, the Company issued 85,000 shares of Common Stock to a consultant in respect of his consulting services for the Company. The Company has estimated the fair value of such shares, and recorded an expense of $5,685. On April 13, 2016, the Company issued 1,000,000 shares of Common Stock to a consultant in consideration for corporate finance, investor communications and financial and investor public relations services. The Company has estimated the fair value of such shares, and recorded an expense of $73 in second fiscal quarter of 2016 and $10 in first fiscal quarter of 2016. On June 13, 2016 and per the consulting agreement the Company issued an additional 1,000,000 shares of common stock as a service bonus since the agreement was not terminated prior to June 9, 2016. The Company has estimated the fair value of such shares, and recorded an expense of $89. On April 13, 2016, the Company issued an aggregate of 875,000 shares of Common Stock to a consultant, pursuant to consulting agreements dated September 1, 2015 and March 1, 2016, in consideration for investor relations and communications services. The Company has estimated the fair value of such shares, and recorded an expense of $42. On May 18, 2016, a 1.5-year warrant to purchase shares of Common Stock, dated May 4, 2015, was exercised into 700,000 shares of Common Stock at an exercise price of $0.058 per share, for total consideration of $41. On June 2, 2016, the Company issued 13,930,742 shares of the Company’s Common Stock in consideration of $146 pursuant to the July 2015 Offering Subscription Agreements. On June 13, 2016, the Company issued 7,103,467 shares of Common Stock to several officers, directors, employees and/or consultants of the Company. All shares were issued pursuant to the Company’s Global Share and Options Incentive Enhancement Plan (2014). The Company has estimated and recorded the fair value of such shares as an expense of $632 which was recorded through 2015 and the 2016. On June 26, 2016, the Company issued 500,000 shares of Common Stock in order to complete its obligations under the Share Purchase Agreement from 2015. On July 14, 2016, the Company cancelled 85,000 shares of Common Stock that were issued in error. In June and July 2016, The Company conducted an offering (the “June 2016 Offering”) consisting of (a) up to $3,000 of shares of Common Stock, priced at the closing price for shares of Common Stock, as reported on the OTCQB Venture Marketplace on the trading day prior to each respective closing of the June Offering, and (b) five-year warrants (the “June Warrants”, together with the shares of Common Stock subscribed for, the “June Securities”) to purchase shares of Common Stock in an amount equal to one hundred percent (100%) of the number of shares of Common Stock so purchased by the subscriber, with an exercise price equal to the per share price of the Common Stock or $0.011 per share, whichever is greater. The June Securities were offered pursuant to subscription agreements with each subscriber (the “June Subscription Agreement”). In addition to other customary provisions, each June Subscription Agreement provides that the Company will use its reasonable commercial efforts to register all shares of Common Stock sold in the June Offering, including all shares of Common Stock underlying the June Warrants, within twenty (20) days of the final closing of the June Offering. Each June Subscription Agreement also provides that if, during the period beginning on the date of the first closing of the June Offering and ending on the six month anniversary thereof, the Company completes (a) a subsequent closing of the June Offering or (b) a public or private offering and sale of $1,000 or more of Common Stock or warrants to purchase Common Stock, where such subsequent closing or offering, as applicable, provides for material deal terms and conditions more favorable than are contained in such June Subscription Agreement, then the June Subscription Agreement will be deemed modified to provide the applicable subscriber with the more favorable deal terms and conditions, and the Company will take all reasonable steps necessary to amend the June Securities and/or issue new securities to the applicable subscriber reflecting such more favorable material deal terms and conditions (the “June MFN Rights”). The June Warrants are exercisable for five years from the date of issuance, include an option by which the holder may exercise the June Warrant by means of a cashless exercise, and include customary weighted-average price adjustment and anti-dilution terms. On July 26, 2016, the Company completed closings of the June Offering, both such closings representing aggregate gross proceeds to the Company of $1,370. In connection with both closings, the Company and subscribers entered into (a) June Subscription Agreements for 18,266,668 shares of Common Stock at $0.075 per share, and (b) June Warrants to purchase up to 18,266,668 shares of Common Stock at an exercise price of $0.11 per share. The subscriber in the July 7, 2016 closing received an adjustment to its June Securities pursuant to its June MFN Rights. The warrants were accounted for as derivative liabilities. The Company engaged Maxim to assist in the June Offering. Pursuant to the terms of an engagement letter between Maxim and the Company, in connection with both closings, Maxim received commissions equal to 4.44% of the gross proceeds raised, warrants to purchase up to 928,000 shares of Common Stock at an exercise price of $0.0825 per share, and warrants to purchase up to 928,000 shares of Common Stock at an exercise price of $0.121 per share. On August 7, 2016, the Company issued 143,000 shares of Common Stock, in consideration for past capital advisory services rendered to the Company. The Company has estimated the fair value of such shares, and recorded an expense of $11. On August 16, 2016, the Company issued 400,000 shares of Common Stock in satisfaction of debt of $24. On September 15, 2016, the Company issued 500,000 shares of Common Stock to a consultant in consideration for communications and investor relations services. The Company has estimated the fair value of such shares, and recorded an expense of $20. On September 15, 2016, the Company issued 500,000 shares of Common Stock to a consultant in consideration for communications and investor relations services. The Company has estimated the fair value of such shares, and recorded an expense of $34. On October 25, 2016, the Company completed a private placement of its securities to JMJ Financial, an accredited investor. Pursuant to the financing, the Company entered into a Securities Purchase Agreement with the investor thereby agreeing to issue shares of Common Stock, notes, and warrants to purchase shares of Common Stock, in exchange for $500 paid at closing and an additional $250 which were paid at December 20, 2016 after the achievement of certain milestones, as well as up to an additional $250 in financing upon the mutual agreement of the Investor and the Company. Pursuant to the terms of such financing, the Company agreed to issue to the investor (i) restricted shares of Common Stock equal to twenty-five percent (25%) of the note principal paid to the Company by the Investor, subject to certain adjustments, (ii) a six (6) month promissory note covering the note principal plus an amount equal to approximately five percent (5%) of the actual note principal, in total $1,053, and (iii) a five (5) year warrant to purchase 10,000,000 shares of Common Stock with an aggregate exercise amount of $750. On December 14, 2016, the Company issued 7,658,129 shares of Common Stock in consideration of $84 pursuant to the July 2015 Offering Subscription Agreement. On December 20, 2016, the Company issued 950,000 shares of Common Stock to the CEO of the Company and 850,000 shares of Common Stock to the Chairman of the Board of the Company under their service agreements with the Company. The Company has estimated and recorded the fair value of such shares as an expense of $50 which was recorded through 2016. On December 30, 2016, the Company issued 850,000 shares of Common Stock to an EVP of the under his service agreement with the Company. The Company has estimated and recorded the fair value of such shares as an expense of $24 which was recorded through 2016. On December 30, 2016, the Company issued 5,775,000 shares of Common Stock to several officers, directors, employees and/or consultants of the Company. All shares were issued pursuant to the Company’s Global Share and Options Incentive Enhancement Plan (2014). The Company has estimated and recorded the fair value of such shares as an expense of $386. On December 30, 2016, the Company issued 300,000 shares of Common Stock, in consideration for past services rendered a member of the Board of Directors to the Company. The Company has estimated the fair value of such shares, and recorded an expense of $20. Share Repurchase Program On June 17, 2015, the Company’s Board of Directors approved a share repurchase program (the “Share Repurchase Program”). Under the Share Repurchase Program, the Company is authorized to repurchase up to $500 worth of its common stock, which, based on the value of the Company’s common stock on December 31, 2016, equates to approximately 7,473,841 shares of common stock. However, the total number of shares could differ based on the ultimate price per share paid by the Company. Further, the Company’s shares of common stock may be purchased on the open market or through privately negotiated transactions from time-to-time and in accordance with applicable laws, rules and regulations. The Company is not obligated to make any purchases, including at any specific time or in any particular situation. The program may be limited or terminated at any time without prior notice. As of December 31, 2016, the Company had not repurchased any shares under the Share Repurchase Program. On June 23, 2015, the Company repurchased 144,054 shares from a shareholder for $28 as part of a settlement with such shareholder. This repurchase was not pursuant to the Share Repurchase Program.

STOCK OPTIONS AND STOCK INCENTI

STOCK OPTIONS AND STOCK INCENTIVE PLANS	12 Months Ended
	Dec. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
STOCK OPTIONS AND STOCK INCENTIVE PLANS	NOTE 15 – STOCK OPTIONS AND STOCK INCENTIVE PLANS On February 24, 2015, the Board of Directors approved a grant of up to 2,575,000 shares of common stock to certain of its managers, directors and key employees under the 2010 Plan, of which 2,575,000 shares were issued as of December 31, 2016. On February 24, 2015, the Company’s Board of Directors approved and adopted the Global Share and Options Incentive Enhancement Plan (2014) (the “2014 Plan”), pursuant to which the Company may award shares of its common stock, options to purchase shares of its common stock and other equity-based awards to eligible participants. The 2014 Plan replaced the Company’s Global Share Incentive Plan (2010). Subject to the terms and conditions of the 2014 Plan, the Board of Directors has full authority in its discretion, from time to time and at any time, to determine (i) eligible participants in the 2014 Plan, (ii) the number of options or shares to be covered by an award, (iii) the time or times at which an award shall be granted, (iv) the vesting schedule and other terms and conditions of an award, (v) the form(s) of written agreements applicable to an award, and (vi) any other matter which is necessary or desirable for, or incidental to, the administration of the 2014 Plan and the granting of awards thereunder. The 2014 Plan permits the grant of up to 13,100,000 shares of common stock and up to 3,175,000 options to purchase shares of common stock to certain of its managers, directors and key employees. The shares will vest on a quarterly basis over a two-year period, and the options will vest on a quarterly basis over a two-year period with an exercise price of $0.14 per share. As of December 2016, 10,733,333 shares granted under the 2016 Incentive Plan have been issued. On August 8, 2016, the Company’s Board of Directors approved and adopted the Global Share and Options Incentive Enhancement Plan (2016) (the “2016 Plan”), pursuant to which the Company may award shares of its common stock, options to purchase shares of its common stock and other equity-based awards to eligible participants. The 2016 Plan replaced the 2014 Plan. Subject to the terms and conditions of the 2016 Plan, the Board of Directors has full authority in its discretion, from time to time and at any time, to determine (i) eligible participants in the 2016 Plan, (ii) the number of options or shares to be covered by an award, (iii) the time or times at which an award shall be granted, (iv) the vesting schedule and other terms and conditions of an award, (v) the form(s) of written agreements applicable to an award, and (vi) any other matter which is necessary or desirable for, or incidental to, the administration of the 2016 Plan and the granting of awards thereunder. The 2016 Plan permits the grant of up to 30,000,000 shares of common stock and up to 15,000,000 options to purchase shares of common stock to certain of its managers, directors and key employees. The shares will vest on a quarterly basis over a two-year period, and the options will vest on a quarterly basis over a two-year period with an exercise price that shall not be less than the Fair Market Value on the date of grant. As of December 31, 2016, all shares and options granted under the 2016 Incentive Plan have not yet been issued. As December 31, 2016 and 2015 778,761 options were outstanding and exercisable all of which with a weighted average exercise price of 0.5763 and an intrinsic value of $9. The following table summarizes information about options to employees, officers and directors outstanding at December 31, 2016 under the plans: Options Outstanding Vested and Exercisable Exercise Price Number of Weighted Average Remaining Contractual Life (Years) Number of Weighted Average Exercise Price 0.5763 778,761 1.33 778,761 0.5763 As of December 31, 2016, the aggregated intrinsic value for the options vested and exercisable was $9 thousand with a weighted average remaining contractual life of 1.33 years.

INCOME TAXES

INCOME TAXES	12 Months Ended
	Dec. 31, 2016
Income Tax Disclosure [Abstract]
INCOME TAXES	NOTE 16 – INCOME TAXES US resident companies are taxed on their worldwide income for corporate income tax purposes at a statutory rate of 35%. No further taxes are payable on this profit unless that profit is distributed. If certain conditions are met, income derived from foreign subsidiaries is tax exempt in the US under applicable tax treaties to avoid double taxation. Taxable income of Israeli companies is subject to tax at the rate of 26.5% in the year 2015, 25% in the year 2016, 24% in the year 2017 and 23% in the year 2018. The Company accounts for income taxes using the liability method, which requires the determination of deferred tax assets and liabilities based on the differences between the financial and tax bases of assets and liabilities using enacted tax rates in effect for the year in which differences are expected to reverse. Deferred tax assets are adjusted by a valuation allowance, if, based on the weight of available evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred income taxes reflect the net effects of temporary differences between the amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The breakdown of the deferred tax asset as of December 31 2016, and 2015 is as follows: 2016 2015 U.S. dollars in thousands Deferred tax assets: Net operating loss carry-forward $ 9,259 $ 6,768 Valuation allowance (9, 259 ) (6,768 ) $ — $ — A valuation allowance is provided when it is more likely than not that some portion of the deferred tax asset will not be realized. Management has determined, based on its recurring net losses, lack of a commercially viable product and limitations under current tax rules, that a full valuation allowance is appropriate. U.S. dollars in thousands Valuation allowance, December 31, 2015 $ 6,768 Increase 2,491 Valuation allowance, December 31, 2016 $ 9,259 Carry forward losses of the Company are approximately $20,635 at December 31, 2016 and available throughout 2036. Carry forward losses of the Israeli subsidiary are approximately $4,114 at December 31, 2016 and have no expiration date. Reconciliation between the theoretical tax expense, assuming all income is taxed at the statutory tax rate applicable to income of the Company and the actual tax expense as reported in the Statement of Operations, is as follows: Year ended December 31, 2016 2015 Loss before taxes, as reported in the consolidated statements of operations $ 7,266 $ 7,462 Federal statutory rate 35 % 35 % Theoretical tax benefit on the above amount at federal statutory tax rate 2,543 2,611 Losses and other items for which a valuation allowance Was provided or benefit from loss carry forward (2,491) (2,611 ) Actual tax expense 52 —

TRANSITION PERIOD FINANCIAL INF

TRANSITION PERIOD FINANCIAL INFORMATION	12 Months Ended
	Dec. 31, 2016
Transition Period Financial Information
TRANSITION PERIOD FINANCIAL INFORMATION	NOTE 17 – TRANSITION PERIOD FINANCIAL INFORMATION In 2016, the Company changed its fiscal year to end on December 31st each year, effective January 1, 2016. The following table presents selected financial data for the transition period, the three months ended and as of December 31, 2015, and three months ended and as of December 31, 2014, (in thousands, except per share data): Three Month Ended December 31, 2015 2014 (unaudited) Consolidated Statement of Operations data: General and administrative expenses $ 1,106 $ 827 Other losses — 19 Financial expenses. net 144 468 Equity Losses in Non-Consolidated Subsidiaries 38 — Net Loss $ 1,288 $ 1,314 Net loss per common share – basic and diluted $ (0.007 ) $ (0.026 ) Weighted average shares outstanding during the period (basic and diluted) 177,011,554 51,031,823 Consolidated Balance Sheet (as of December 31, 2014, Unaudited): Total Current Assets $ 404 Total Non-Current Assets 509 Total Assets $ 913 Total Current liabilities $ 1,234 Long Tern Bank Loan 126 Total stockholders’ equity (447 ) Total Liabilities and stockholders’ deficit $ 913

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Dec. 31, 2016
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 18 – SUBSEQUENT EVENTS On January 31, 2017, the Company issued 404,167 shares of Common Stock to the Former Chief Financial Officer (Israel) of the Company and 350,000 shares of Common Stock to Former Chief Financial Officer (U.S.) of the Company under their departure settlement agreements with the Company. On January 31, 2017, the Company dissolved Johnstonsphere, LLC. On February 1, 2017, the Board of Directors approved the Company’s Amended and Restated Non-Employee Director Compensation Policy, applicable to members of the Board who are not employees of the Company. Under the Amended Director Compensation Policy, beginning on January 1, 2016 each Eligible Director shall be entitled to an annual cash retainer of USD $20, paid semi-annually, and a quarterly stock awards equal to $13, determined based on the closing price of a share of Common Stock on the last trading day of such quarter, as reported on the OTCQB® Venture Marketplace. Eligible Directors shall also receive meeting fees equal to (a) $1.5 for scheduled quarterly meetings of the Board attended in-person, (b) $0.5 for scheduled quarterly meetings of the Board attended by teleconference, (c) USD $0.25 for special meetings of the Board, and (d) $0.5 for meetings of the committees of the Board. If an Eligible Director attends a meeting of the Board and one or more meetings of a committee of the Board on the same date, the Eligible Director shall receive the full fee for the meeting of the Board and 50% of the fee for each meeting of a committee of the Board attended. On February 13, 2017, the Company entered into a 90 days Loan Agreement with Viskoben Limited to borrow $200 at interest rate of ten percent (10.0%).

SIGNIFICANT ACCOUNTING POLICI26

SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2016
Accounting Policies [Abstract]
Functional currency	a. Functional currency The functional currency of the company is U.S dollar. The functional currency of the subsidiaries is also U.S dollar, except for Blue Sphere Pavia. Accordingly, all monetary assets, liabilities, expenses and equity earnings of the foreign subsidiary are re-measured into U.S. dollars at the exchange rates in effect at the reporting date. The foreign currency translation adjustments are included as a component in the stockholders’ Deficit in the accompanying consolidated balance sheet as a component of accumulated other Comprehensive Loss.
Basis of Presentation	b. Basis of Presentation The consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and includes the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.
Cash equivalents	c. Cash equivalents Cash equivalents are short-term highly liquid investments which include short term bank deposit (up to three months from date of deposit), that are not restricted as to withdrawals or use that are readily convertible to cash with maturities of three months or less as of the date acquired.
Fair Value of Financial Instruments	d. Fair Value of Financial Instruments The Company records its financial assets and liabilities at fair value. The accounting guidance for fair value provides a framework for measuring fair value, clarifies the definition of fair value, and expands disclosures regarding fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The accounting guidance establishes a three-tiered hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value: Level 1 – Quoted prices in active markets for identical assets or liabilities. Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The Company recognizes transfers among Level 1, Level 2 and Level 3 classifications as of the actual date of the events or change in circumstances that caused the transfers. The Company’s financial instruments, including cash equivalents, accounts payable and accrued liabilities have carrying amounts which approximate fair value due to the short-term maturity of these instruments.
Property, plant and equipment	e. Property, plant and equipment Property, plant and equipment are stated at cost, less accumulated depreciation. Assets are depreciated using the straight-line method over their estimated useful lives. Annual rates of depreciation are as follows: % Computers, electronic equipment and software 33 Vehicles 15 Office furniture and equipment 15
Investment in non-consolidated variable interests entities	f. Investment in nonconsolidated affiliates Investments in companies in which the Company has the ability to exert significant influence over operating and financial policies (generally 20% to 50% ownership), but which the Company does not control, are accounted for using the equity method. Under the equity method, investments are initially recorded at cost and adjusted for dividends and undistributed earnings and losses. The Company evaluates its investments in nonconsolidated Affiliates for impairment whenever events or changes in circumstances indicate that the carrying value of such investments may have experienced a decline in value. When there is evidence of loss in value that is other than temporary, the Company compares the estimated fair value of the investment to the carrying value of the investment to determine whether impairment has occurred. If the estimated fair value is less than the carrying value, the excess of the carrying value over the estimated fair value is recognized as an impairment loss.
Use of estimates	g. Use of estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results may differ from those estimates. On an on-going basis, management evaluates its estimates, judgments and assumptions. Those estimates and assumptions affect including investments in nonconsolidated affiliates, investments in non-consolidated subsidiaries, deferred revenue from nonconsolidated affiliates, contingencies and litigation, income taxes and determination of fair value of stock-based compensation. These estimates are based available as of the date of the consolidated financial statements; therefore, actual results could differ from management’s estimates.
Loss per share	h. Loss per share Net loss per share, basic and diluted, is computed on the basis of the net loss for the period divided by the weighted average number of common shares outstanding during the period. Diluted net loss per share is based upon the weighted average number of common shares and of common shares equivalents outstanding when dilutive. Common share equivalents include: (i) outstanding stock options under the Company’s share incentive plan and warrants which are included under the treasury share method when dilutive, and (ii) common shares to be issued under the assumed conversion of the Company’s outstanding convertible notes, which are included under the if-converted method when dilutive. The computation of diluted net loss per share for the years ended December 31, 2016 and September 30, 2015 and for the three months period ended December 31, 2015 does not include common share equivalents, since such inclusion would be anti-dilutive.
Income taxes	i. Income taxes The Company account for income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in Company’s consolidated financial statements or in our tax returns. Estimates and judgments occur in the calculation of certain tax liabilities and in the determination of the recoverability of certain deferred income tax assets, which arise from temporary differences and carryforwards. Deferred income tax assets and liabilities are measured using the currently enacted tax rates that apply to taxable income in effect for the years in which those tax assets are expected to be realized or settled. Management regularly assess the likelihood that deferred tax assets will be recovered from future taxable income and, to the extent that management believe, based upon the weight of available evidence, that it is more likely than not that all or a portion of deferred tax assets will not be realized, a valuation allowance is established through an adjustment to income tax expense. The factors used to assess the likelihood of realization of our deferred tax assets include the Company’s forecast of future taxable income and available tax planning strategies that could be implemented to realize the net deferred tax assets. Assumptions represent management’s best estimates and involve inherent uncertainties and the application of management’s judgment. The Company account for uncertainty in income taxes recognized in the Company’s consolidated financial statements by regularly reviewing our tax positions and benefits to be realized. The Company’s recognize tax liabilities based upon management’s estimate of whether, and the extent to which, additional taxes will be due when such estimates are more-likely-than-not to be sustained. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained upon examination by taxing authorities. The provision for income taxes includes the effects of any resulting tax reserves, or unrecognized tax benefits, that are considered appropriate as well as the related net interest and penalties.
Comprehensive loss	j. Comprehensive loss Comprehensive income (loss) consists of net income (loss) and other gains and losses affecting equity that under US GAAP are excluded from net income (loss). For the Company, such items consist of translation adjustments.
Revenues from Services	k. Revenues from Services The Company recognizes revenues from Development Fees in accordance with ASC Topic 605-20 Revenue Recognition from Services.
Treasury shares	l. Treasury shares Treasury shares are held by the Company and presented as a reduction of the Company shareholders’ deficit and carried at their cost to the Company, under treasury shares.
Stock-based compensation	m. Stock-based compensation The Company recognizes the estimated fair value of share-based awards under stock-based compensation cost. The Company measures compensation expense for share-based awards based on estimated fair values on the date of grant using the Black-Scholes option-pricing model. This option pricing model requires estimates as to the option’s expected term and the price volatility of the underlying stock. The Company measures compensation expense for the shares based on the market value of the underlying stock at the date of grant, less an estimate of dividends that will not accrue to the shares holders prior to vesting. The Company elected to recognize compensation cost for awards that have a graded vesting schedule using the straight-line approach. Share-based payments to non-employees are measured at the fair value of the goods or services received or the fair value of the equity instruments issued if it is determined the fair value of the goods or services cannot be reliably measured, and are recorded at the date the goods or services are received. The amount recognized as an expense is adjusted to reflect the number of awards expected to vest. The fair value of equity awards is charged to the statement of operations over the service period. The offset to the recorded cost is to additional Paid in Capital. Consideration received on the exercise of stock options is recorded as capital stock and the related share-based payments reserve is transferred to share capital.
Contingencies	n. Contingencies The Company is involved in various commercial and other legal proceedings that arise from time to time in the ordinary course of business. Except for income tax contingencies or contingent consideration or other contingent liabilities incurred or acquired in a business combination, the Company records accruals for these types of contingencies to the extent that Company concludes their occurrence is probable and that the related liabilities are reasonably estimated. When accruing these costs, the Company will recognize an accrual in the amount within a range of loss that is the best estimate within the range. When no amount within the range is a better estimate than any other amount, the Company accrues for the minimum amount within the range. Legal costs are expensed as incurred. Contingent consideration and other contingent liabilities incurred or acquired in a business combination are recorded at a probability weighted assessment of their fair value and monitored on an ongoing basis for changes in that value.
Newly issued accounting pronouncements	o. Newly issued accounting pronouncements In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes the revenue recognition requirements in Accounting Standards Codification (“ASC”) 605, Revenue Recognition. The new revenue recognition standard requires entities to recognize revenue in a way that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. In August 2015, the FASB issued Accounting Standards Update No. 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date, or ASU 2015-14. This amendment defers the effective date of the previously issued Accounting Standards Update ASU 2014-09, until the interim and annual reporting periods beginning after December 15, 2017. Earlier application is permitted for interim and annual reporting periods beginning after December 15, 2016. In August 2015, the FASB has issued Accounting Standards Update (ASU) No. 2015-15, Interest - Imputation of Interest (Subtopic 835-30): Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements - Amendments to SEC Paragraphs Pursuant to Staff Announcement at June 18, 2015 EITF Meeting . This ASU adds SEC paragraphs pursuant to the SEC Staff Announcement at the June 18, 2015, Emerging Issues Task Force meeting about the presentation and subsequent measurement of debt issuance costs associated with line-of-credit arrangements. Given the absence of authoritative guidance within ASU 2015-03 for debt issuance costs related to line-of-credit arrangements, the SEC staff would not object to an entity deferring and presenting debt issuance costs as an asset and subsequently amortizing the deferred debt issuance costs ratably over the term of the line-of-credit arrangement, regardless of whether there are any outstanding borrowings on the line-of-credit arrangement. The Company does not expect this update will have a material impact on the presentation of the Company’s consolidated financial position, results of operations and cash flows. In November 2015, the FASB has issued Accounting Standards Update (ASU) No. 2015-17, Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes, which changes how deferred taxes are classified on organizations’ balance sheets. The ASU eliminates the current requirement for organizations to present deferred tax liabilities and assets as current and noncurrent in a classified balance sheet. Instead, organizations will be required to classify all deferred tax assets and liabilities as noncurrent. The amendments apply to all organizations that present a classified balance sheet. For public companies, the amendments are effective for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods. The Company does not expect this update will have a material impact on the presentation of the Company’s consolidated financial position, results of operations and cash flows.

SIGNIFICANT ACCOUNTING POLICI27

SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Dec. 31, 2016
Accounting Policies [Abstract]
Schedule of annual rates of depreciation	Annual rates of depreciation are as follows: % Computers, electronic equipment and software 33 Vehicles 15 Office furniture and equipment 15

FAIR VALUE MEASUREMENT (Tables)

FAIR VALUE MEASUREMENT (Tables)	12 Months Ended
	Dec. 31, 2016
Fair Value Disclosures [Abstract]
Schedule of company's financial assets and liabilities that are measured at fair value on a recurring basis by level	The Company’s financial assets and liabilities that are measured at fair value on a recurring basis by level within the fair value hierarchy are as follows (in thousands): As of December 31, 2016 Level 1 Level 2 Level 3 Total Liabilities: Obligation to issue shares of Common Stock $ 187 $ — $ — $ 187 Deferred payment due to the acquisition of the SPVs $ — $ — $ 2,685 $ 2,685 Warrants Liability $ — $ — $ 2,045 $ 2,045 Total liabilities $ 187 $ — $ 4,730 $ 4,917 Balance as of December 31, 2015, Level 1 Level 2 Level 3 Total Liabilities: Deferred payment due to the acquisition of the SPVs $ — $ — $ 2,910 $ 2,910 Warrants liability $ — $ — $ 544 $ 544 Total liabilities $ — $ — $ 3,454 $ 3,454
Schedule of Deferred payment due to the acquisition of the SPVs	The Deferred payment due to the acquisition of the SPVs is included in long term loans and Liabilities in the consolidated Balance Sheets and the change in fair value of remaining balance is included in interest expenses in the consolidated statements of income. Deferred payment due to the acquisition of the SPVs Balance at January 1, 2015 $ — Increase due to acquisition of the SPVs 2,910 Balance at December 31, 2015 $ 2,910 Changes in fair value, interest expense and translation adjustments (225) Balance at December 31, 2016 $ 2,685
Schedule of Level 3 liabilities	As of December 31,2016, and 2015, the Level 3 liabilities consisted of the Company’s warrant liability. Warrants Liability Balance at January 1, 2015 $ — Issuance of warrants 325 Changes in fair value 219 Balance at December 31, 2015 $ 544 Issuance of warrants 2,839 Changes in fair value 1,338 Balance at December 31, 2016 $ 2,045

INVESTMENTS IN NONCONSOLIDATE29

INVESTMENTS IN NONCONSOLIDATED AFFILIATES (Tables)	12 Months Ended
	Dec. 31, 2016
Investments in and Advances to Affiliates, Schedule of Investments [Abstract]
Schedule of Investment in nonconsolidated affiliates	Investment in nonconsolidated affiliates consists of the following: December 31, 2016 December 31, 2015 Carrying Value (In thousands) Ownership Percentage Carrying Value (In thousands) Ownership Percentage Investment in Concord Energy Partners, LLC $ 5,960 25.00 % $ 4,795 25.00 % Rhode Island Energy Partners LLC $ 4,177 22.75 % $ 2,775 22.75 % Total $ 10,137 $ 7,570
Schedule of deferred revenues from nonconsolidated affiliates	Deferred revenues from nonconsolidated affiliates consists of the following: December 31, 2016 December 31, 2015 Carrying Value (In thousands) Ownership Percentage Carrying Value (In thousands) Ownership Percentage Deferred revenues from Concord Energy Partners, LLC $ — 25.00 % $ 4,795 25.00 % Deferred revenues from Rhode Island Energy Partners LLC $ 4,177 22.75 % $ 2,776 22.75 % Deferred Revenue from Services from Rhode Island Energy Partners LLC $ 1,481 22.75 % $ 1,481 22.75 % Total $ 5,658 $ 9,052
Summary of the combined financial information related to the nonconsolidated affiliates under the equity method	The tables set forth below summarize the combined financial information related to the nonconsolidated affiliates that are accounted for under the equity method as of December 31, 2016, and December 31,2015. December 31, 2016 (Dollars in thousands) Concord Rhode Island Assets: Restricted Cash $ 500 $ 751 Property, Plant and Equipment, net of accumulated depreciation 26,169 19,230 Total assets $ 26,669 $ 19,981 Current liabilities $ 652 $ 142 Membership Interest 26,017 19,839 Total liabilities and Membership Interest $ 26,669 $ 19,981 December 31, 2015 (Dollars in thousands) Concord Rhode Island Assets: Property, Plant and Equipment, net of accumulated depreciation $ 22,878 15,901 Other assets 17 — Total assets $ 22,895 $ 15,901 Current liabilities $ 2,127 $ 2,224 Membership Interest 20,768 13,677 Total liabilities and Membership Interest $ 22,895 $ 15,901

INVESTMENTS IN NONCONSOLIDATE30

INVESTMENTS IN NONCONSOLIDATED SUBSIDIARIES (Tables)	12 Months Ended
	Dec. 31, 2016
Equity Method Investments and Joint Ventures [Abstract]
Schedule of investments in nonconsolidated subsidiaries	Investment in nonconsolidated subsidiaries included the following activity during the years: Year ended December 31, 2016 2015 Balance at beginning of period $ 4,993 $ — Investment in nonconsolidated subsidiaries — 5,031 Equity in losses of nonconsolidated subsidiaries (444 ) (38 ) Translation adjustment (120 ) — Balance at end of period $ 4,429 $ 4,993
Summary of the combined financial information related to our nonconsolidated subsidiaries under the equity method	The table set forth below summarize the combined financial information related to our nonconsolidated subsidiaries that are accounted for under the equity method as of December 31, 2016, and December 31, 2015. (Dollars in thousands) December 31, 2016 December 31, 2015 Assets: Current Assets $ 2,735 $ 2,753 Property, Plant and Equipment, net of accumulated depreciation 16,167 18,109 Other Non-Current Assets 7,970 6,054 Total assets $ 26,872 $ 26,916 Liabilities and Shareholder’s Deficit: Current liabilities $ 8,221 $ 4,697 Long Term Liabilities 14,282 17,286 Total liabilities 22,503 21,983 Shareholder’s Equity 4,369 4,933 Total Shareholder’s Equity 4,369 4,933 Total liabilities and Shareholder’s Equity $ 26,872 $ 26,916

CURRENT MATURITIES OF DEBENTU31

CURRENT MATURITIES OF DEBENTURES AND LONG TERM LOANS (Tables)	12 Months Ended
	Dec. 31, 2016
Debt Disclosure [Abstract]
Schedule of Current Maturities of Debentures and Long Term Loans	Current Maturities of Debentures and Long Term Loans consisted of the following: Interest rate as of December 31, 2016 December 31, 2016 December 31, 2015 Debentures 11% $ 2,658 $ — Current Maturities portion of Loan from Helios 14.5% 289 517 Current Maturities Long Term Loan from Bank 1.8-6% 41 32 Total Current Maturities of Debentures and Long Term Loans $ 2,988 $ 549

LONG TERM LOANS AND LIABILITI32

LONG TERM LOANS AND LIABILITIES (Tables)	12 Months Ended
	Dec. 31, 2016
Debt Disclosure [Abstract]
Schedule of Long-term loans and liabilities	Long-term loans and liabilities consisted of the following: Interest rate as of December 31, 2016 December 31, 2016 December 31, 2015 Deferred payment due to the acquisition of the SPVs (1) 2% $ 2,685 $ 2,910 Long Term portion of Loan from Helios (2) 14.5% 2,607 3,149 Total current assets $ 5,292 $ 6,059 Less: current maturities of Long Term portion of Loan from Helios (2) 14.5% 289 516 $ 5,003 $ 5,543 (1) Represents the remaining balance of fifty percent (50%) of the Purchase Price that is due to the Sellers on the third anniversary of the closing date. This amount will be adjusted to the variation of EBITDA as described above and is promised by a note to each Seller, to be paid on the third anniversary of the closing, along with interest on the unpaid balance due at an annual rate of two percent (2%). The fair value measurement of the fair market value of the remaining balance is based on significant inputs not observed in the market and thus represents a Level 3 measurement, which reflects the Company’s own assumptions in measuring fair value. The Company estimated the fair value of the remaining balance using the discounted cash flow model. Key assumptions include the level and timing of the expected future payment and discount rate consistent with the level of risk and economy in general. The balance of the Deferred payment due to the acquisition of the SPVs is included in long term loans and Liabilities in the consolidated Balance Sheets and the change in fair value of remaining balance is included in interest expenses in the consolidated statements of income. (2) In 2015, the Company entered into a Long Term Mezzanine Loan Agreement (the “Helios Loan Agreement”) with Helios Italy Bio-Gas 1 L.P. (“Helios”) to finance the acquisition of the SPVs. Under the Helios Loan Agreement, the Company borrowed €2,900,000 ($3,149,000) at annual interest rate of fourteen and one-half percent (14.5%), paid quarterly. Helios is also entitled to an annual operation fee of one and one-half percent (1.5%), paid quarterly. The final payment of the loan will become due no later than the earlier of (a) thirteen and one half years from the date such loan was made available to the Company, and (b) the date that the Feed in Tariff license granted to the relevant SVP expires. Pursuant to the Helios Loan Agreement, the Company pledged all its shares in Eastern and Bluesphere Pavia to secure the outstanding balance under the Helios Loan Agreement.

WARRANTS LIABILITY (Tables)

WARRANTS LIABILITY (Tables)	12 Months Ended
	Dec. 31, 2016
Warrants Liability Tables
Schedule of warrants liability	At each balance sheet date, the Company had the following warrants to purchase common stock outstanding: Fair value Fair value Warrants of Warrants Warrants of Warrants outstanding Liabilities as of outstanding Liabilities as of as of December 31, 2016 as of December 31, 2015 December 31, 2016 (in thousands) December 31, 2015 (in thousands) May 1, 2014 Warrants ($0.10 per share) 1,500,000 $ 26 1,500,000 $ — November 2015 Warrants ($0.05 per share) (1) 4,000,000 155 4,000,000 175 November 2015 Warrants ($0.075 per share) (1) 4,000,000 128 4,000,000 174 November 2015 Warrants ($0.06875 per share) (1) 4,480,000 150 4,480,000 195 February 3, 2016 Warrants ($0.06 per share) (2) 1,500,000 42 — — February 2016 Offering ($0.10 per share) (3) 17,500,000 485 — — February 2016 Offering ($0.061 per share) (3) 2,800,000 101 — — February 2016 Offering ($0.11 per share) (3) 1,400,000 36 — — July 2016 Offering ($0.11 per share) (4) 18,266,668 512 — — July 2016 Offering ($0.121 per share) (4) 928,000 25 — — July 2016 Offering ($0.083 per share) (4) 928,000 30 — — October 2016 Offering ($0.075 per shares) (5) 10,000,000 353 — — Total 67,302,668 $ 2,045 13,980,000 $ 544 Average date to maturity (in years) 4.25 4.78 Average exercise price $ 0.0901 $ 0.06825
Schedule of fair value inputs of warrants	(1) Pursuant to the November 2015 Offering, the Company sold warrants to purchase up to 4,000,000 shares of Common Stock at an exercise price per share of $0.05 and warrants to purchase up to 4,000,000 shares of Common Stock at an exercise price per share of $0.075. The Warrants are exercisable until December 22, 2020 and were accounted for as derivative liabilities. The Company has estimated the fair value of such warrants at a value of $209 at the date of issuance using the Black-Scholes option pricing model using the following assumptions: % Dividend yield 0 % Risk-free interest rate 1.74 % Expected term (years) 5 Volatility 202 % The Company has estimated the fair value of such warrants at a value of $117 at the date of issuance using the Black-Scholes option pricing model using the following assumptions: % Dividend yield 0 % Risk-free interest rate 1.74 % Expected term (years) 5 Volatility 202 % (2) On February 3, 2016, the Company issued warrants to purchase up to 1,500,000 shares of our common stock of the Company at an exercise price of $0.06 per share, in full satisfaction of certain obligations of the Company. The Warrants are exercisable until February 2, 2019 and were accounted for as derivative liabilities. The Company has estimated the fair value of such warrants at a value of $87 at the date of issuance using the Black-Scholes option pricing model using the following assumptions: % Dividend yield 0 % Risk-free interest rate 1.20 % Expected term (years) 3 Volatility 203 % (3) Pursuant to the February 2016 Offering, the Company sold warrants to purchase up to 17,500,000 shares of Common Stock at an exercise price per share of $0.10. The Warrants are exercisable until February 14, 2021 and were accounted for as derivative liabilities. The Company has estimated the fair value of such warrants at a value of $847 at the date of issuance using the Black-Scholes option pricing model using the following assumptions: % Dividend yield 0 % Risk-free interest rate 1.20 % Expected term (years) 5 Volatility 203 % The Company has estimated the fair value of such warrants at a value of $204 at the date of issuance using the Black-Scholes option pricing model using the following assumptions: % Dividend yield 0 Risk-free interest rate 1.20 % Expected term (years) 5 Volatility 203 % (4) Pursuant to the July 2016 Offering, the Company sold warrants to purchase up to 18,266,668 shares of Common Stock at an exercise price per share of $0.11. The Warrants are exercisable until July 25, 2021 and were accounted for as derivative liabilities. The Company has estimated the fair value of such warrants at a value of $1,140 at the date of issuance using the Black-Scholes option pricing model using the following assumptions: % Dividend yield 0 % Risk-free interest rate 1.00 % Expected term (years) 5 Volatility 147 % The Company has estimated the fair value of such warrants at a value of $117 at the date of issuance using the Black-Scholes option pricing model using the following assumptions: % Dividend yield 0 Risk-free interest rate 1.00 % Expected term (years) 5 Volatility 147 % (5) Pursuant to the October 2016 Offering, the Company sold warrants to purchase up to 10,000,000 shares of Common Stock at an exercise price per share of $0.075. 6,666,666 Warrants are exercisable until October 24, 2021 and the balance are exercisable until December 19, 2021. The warrants were accounted for as derivative liabilities. The Company has estimated the fair value of such warrants at a value of $504 at the date of issuances using the Black-Scholes option pricing model using the following assumptions: % Dividend yield 0 % Risk-free interest rate 1.75-2.04 % Expected term (years) 5 Volatility 77-89 %

COMMON SHARES (Tables)

COMMON SHARES (Tables)	12 Months Ended
	Dec. 31, 2016
Stockholders' Equity Note [Abstract]
Schedule of shares of common stock reserved for issuance	The Company had shares of common stock reserved for issuance as follows: Year ended December 31, 2016 2015 Outstanding warrants to purchase common stock 67,302,668 13,980,000 Outstanding Options to purchase common stock 778,761 778,761 Approved but not Outstanding Options to purchase common stock — 3,175,000 Unvested Common Stock under the 2014 Incentive Plan 962,500 7,316,667 Common Stock reserved under the 2016 Incentive Plan 30,000,000 — Option to purchase Common Stock reserved under the 2016 Incentive Plan 15,000,000 — Common Stock reserved under the October 2016 Offering 57,000,000 — Total shares reserved for issuance 171,043,929 25,250,428

STOCK OPTIONS AND STOCK INCEN35

STOCK OPTIONS AND STOCK INCENTIVE PLANS (Tables)	12 Months Ended
	Dec. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Summary of stock options to employees, officers and directors outstanding	The following table summarizes information about options to employees, officers and directors outstanding at December 31, 2016 under the plans: Options Outstanding Vested and Exercisable Exercise Price Number of Weighted Average Remaining Contractual Life (Years) Number of Weighted Average Exercise Price 0.5763 778,761 1.33 778,761 0.5763

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Dec. 31, 2016
Income Tax Disclosure [Abstract]
Schedule of deferred tax assets	The breakdown of the deferred tax asset as of December 31 2016, and 2015 is as follows: 2016 2015 U.S. dollars in thousands Deferred tax assets: Net operating loss carry-forward $ 9,259 $ 6,768 Valuation allowance (9, 259 ) (6,768 ) $ — $ —
Summary of valuation allowance of deferred taxes	U.S. dollars in thousands Valuation allowance, December 31, 2015 $ 6,768 Increase 2,491 Valuation allowance, December 31, 2016 $ 9,259
Schedule of reconciliation between the theoretical tax expense	Reconciliation between the theoretical tax expense, assuming all income is taxed at the statutory tax rate applicable to income of the Company and the actual tax expense as reported in the Statement of Operations, is as follows: Year ended December 31, 2016 2015 Loss before taxes, as reported in the consolidated statements of operations $ 7,266 $ 7,462 Federal statutory rate 35 % 35 % Theoretical tax benefit on the above amount at federal statutory tax rate 2,543 2,611 Losses and other items for which a valuation allowance Was provided or benefit from loss carry forward (2,491) (2,611 ) Actual tax expense 52 —

TRANSITION PERIOD FINANCIAL I37

TRANSITION PERIOD FINANCIAL INFORMATION (Tables)	12 Months Ended
	Dec. 31, 2016
Transition Period Financial Information Tables
Schedule of financial data for the three months	In 2016, the Company changed its fiscal year to end on December 31st each year, effective January 1, 2016. The following table presents selected financial data for the transition period, the three months ended and as of December 31, 2015, and three months ended and as of December 31, 2014, (in thousands, except per share data): Three Month Ended December 31, 2015 2014 (unaudited) Consolidated Statement of Operations data: General and administrative expenses $ 1,106 $ 827 Other losses — 19 Financial expenses. net 144 468 Equity Losses in Non-Consolidated Subsidiaries 38 — Net Loss $ 1,288 $ 1,314 Net loss per common share – basic and diluted $ (0.007 ) $ (0.026 ) Weighted average shares outstanding during the period (basic and diluted) 177,011,554 51,031,823 Consolidated Balance Sheet (as of December 31, 2014, Unaudited): Total Current Assets $ 404 Total Non-Current Assets 509 Total Assets $ 913 Total Current liabilities $ 1,234 Long Tern Bank Loan 126 Total stockholders’ equity (447 ) Total Liabilities and stockholders’ deficit $ 913

GENERAL (Details Narrative)

GENERAL (Details Narrative) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Dec. 31, 2014	Sep. 30, 2014
General Details Narrative
Cash	$ 416	$ 1,888	$ 161		$ 298
Working capital deficit	9,669
Stockholders' deficit	(2,224)	(3,486)	$ (2,694)	$ (447)	$ 310
Accumulated deficit	$ (46,493)	$ (44,692)

SIGNIFICANT ACCOUNTING POLICI39

SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - Affiliated Entity [Member]	Dec. 31, 2016
Minimum [Member]
Ownership percentage	20.00%
Maximum [Member]
Ownership percentage	50.00%

SIGNIFICANT ACCOUNTING POLICI40

SIGNIFICANT ACCOUNTING POLICIES (Details)	12 Months Ended
	Dec. 31, 2016
Computers Electronic Equipment and Software [Member]
Annual rates of depreciation	33.00%
Vehicles [Member]
Annual rates of depreciation	15.00%
Office Furniture and Equipment [Member]
Annual rates of depreciation	15.00%

FAIR VALUE MEASUREMENT (Details

FAIR VALUE MEASUREMENT (Details) - Fair Value, Measurements, Recurring [Member] - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Liabilities:
Obligation to issue restricted shares of Common Stock	$ 187	$ 2,910
Deferred payment due to the acquisition of the SPVs	2,685
Warrants Liability	2,045	544
Total liabilities	4,917	3,454
Fair Value, Level 1 [Member]
Liabilities:
Obligation to issue restricted shares of Common Stock	187
Total liabilities	187
Fair Value, Level 3 [Member]
Liabilities:
Obligation to issue restricted shares of Common Stock		2,910
Deferred payment due to the acquisition of the SPVs	2,685
Warrants Liability	2,045	544
Total liabilities	$ 4,730	$ 3,454

FAIR VALUE MEASUREMENT (Detai42

FAIR VALUE MEASUREMENT (Details 1) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Balance at beginning	$ 544
Balance at end	2,045	$ 544
Deferred payment due to the acquisition of the SPVs [Member]
Balance at beginning	2,910
Increase due to acquisition of the SPVs		2,910
Changes in fair value, interest expense and translation adjustments	(98)
Balance at end	$ 2,685	$ 2,910

FAIR VALUE MEASUREMENT (Detai43

FAIR VALUE MEASUREMENT (Details 2) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at beginning	$ 544
Issuance of warrants	2,839	325
Changes in fair value	1,338	219
Balance at end	$ 2,045	$ 544

INVESTMENTS IN NONCONSOLIDATE44

INVESTMENTS IN NONCONSOLIDATED AFFILIATES (Details Narrative) - USD ($)	Jan. 30, 2015	Jan. 07, 2015	Jan. 07, 2015	Jan. 30, 2015	Apr. 08, 2015
Feedstock tipping fee excess profits rate		80.00%
Rhode Island Development and Indemnification Agreement [Member]
Ownership percentage					30.00%
Feedstock tipping fee excess profits rate			80.00%
Business combination, assets and liabilities arising from contingencies, amount recognized, net					$ 1,482,000
Amended OERI Purchase Agreement [Member]
Ownership percentage					22.75%
Development fees and reimbursements received					$ 563,000
York Renewable Energy Partners LLC [Member]
Payments to be received upon operation of project	$ 587,000
Ownership percentage	25.00%			25.00%
Unpaid rate of return				9.00%
Feedstock tipping fee excess profits rate				20.00%
Unpaid rate of return upon liquidation				9.00%
Business combination, assets and liabilities arising from contingencies, amount recognized, net	$ 1,250,000			$ 1,250,000
York Renewable Energy Partners LLC [Member] | Amended OERI Purchase Agreement and New OERI Purchase Agreement [Member]
Feedstock tipping fee excess profits rate		20.00%
Unpaid rate of return upon liquidation		9.00%

IINVESTMENTS IN NONCONSOLIDATED

IINVESTMENTS IN NONCONSOLIDATED AFFILIATES (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Investments in unconsolidated variable interest entities	$ 10,137	$ 7,570
Concord Energy Partners [Member]
Investments in unconsolidated variable interest entities	$ 5,960	$ 4,795
Ownership percentage	25.00%	25.00%
Rhode Island Energy Partners [Member]
Investments in unconsolidated variable interest entities	$ 4,177	$ 2,775
Ownership percentage	22.75%	22.75%

INVESTMENTS IN NONCONSOLIDATE46

INVESTMENTS IN NONCONSOLIDATED AFFILIATES (Details 1) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Deferred revenues from unconsolidated affiliates	$ 5,658	$ 9,052
Concord Energy Partners [Member]
Ownership percentage	25.00%	25.00%
Concord Energy Partners [Member] | Deferred Revenue [Member]
Deferred revenues from unconsolidated affiliates		$ 4,795
Ownership percentage	25.00%	25.00%
Rhode Island Energy Partners [Member]
Ownership percentage	22.75%	22.75%
Rhode Island Energy Partners [Member] | Deferred Revenue [Member]
Deferred revenues from unconsolidated affiliates	$ 4,177	$ 2,776
Ownership percentage	22.75%	22.75%
Rhode Island Energy Partners [Member] | Deferred Revenue from Services [Member]
Deferred revenues from unconsolidated affiliates	$ 1,481	$ 1,481
Ownership percentage	22.75%	22.75%

INVESTMENTS IN NONCONSOLIDATE47

INVESTMENTS IN NONCONSOLIDATED AFFILIATES (Details 2) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Concord Energy Partners [Member]
Assets
Restricted cash	$ 500
Property, plant and equipment, net of accumulated depreciation	26,169	$ 22,878
Other assets		17
Total Assets	26,669	22,895
Total Current Liabilities	652	2,127
Total membership interest	26,017	20,768
Total Liabilities and Membership Interest	26,669	22,895
Rhode Island Energy Partners [Member]
Assets
Restricted cash	751
Property, plant and equipment, net of accumulated depreciation	19,230	15,901
Total Assets	19,981	15,901
Total Current Liabilities	142	2,224
Total membership interest	19,839	13,677
Total Liabilities and Membership Interest	$ 19,981	$ 15,901

INVESTMENTS IN NONCONSOLIDATE48

INVESTMENTS IN NONCONSOLIDATED SUBSIDIARIES (Details Narrative)	Jul. 17, 2015USD ($)	Jul. 17, 2015EUR (€)	May 14, 2015USD ($)	May 14, 2015EUR (€)	Dec. 31, 2016USD ($)	Aug. 18, 2015EUR (€)
Nonconsolidated Subsidiaries [Member]
Investment in SPV carry value exceeded share of net assets | $					$ 19,000
Performance EBITDA Guarantee [Member]
Monthly EBITDA | $	$ 204,000
Annual EBITDA | $	$ 4,083,000
Percentage of excess revenue to be received	90.00%	90.00%
Euro | Performance EBITDA Guarantee [Member]
Monthly EBITDA		€ 188,000
Annual EBITDA		€ 3,760,000
Share Purchase Agreement [Member]
Ownership percentage			100.00%	100.00%
Purchase price | $			$ 5,647,000
Debt interest rate			2.00%	2.00%
Percentage of purchase price paid at closing			50.00%	50.00%
Reimbursed amount				€ 1,160,000
EBITDA adjustment			1.5	1.5
Share Purchase Agreement [Member] | Minimum [Member]
Financed investment SPVS, no repayment (percent)						70.00%
Share Purchase Agreement [Member] | Maximum [Member]
Financed investment SPVS, no repayment (percent)						80.00%
Share Purchase Agreement [Member] | Euro
Purchase price				€ 5,200,000
EBITDA adjustment			935	935
Share Purchase Agreement [Member] | Helios Loan Agreement [Member]
Financed investment intial SPVS (percent)						90.00%
Financed investment subsequentled acquired SPVs (percent)						80.00%
Required repayment of loan and broker fees (percent)						10.00%
Debt interest rate						14.50%
Percentage of annual operation fee						1.50%
Share Purchase Agreement [Member] | Helios Loan Agreement [Member] | Euro
Amount available under loan agreement						€ 5,000,000

INVESTMENTS IN NONCONSOLIDATE49

INVESTMENTS IN NONCONSOLIDATED SUBSIDIARIES (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Investments in nonconsolidated subsidiaries, beginning	$ 4,993
Investments in nonconsolidated subsidiaries, ending	4,429	$ 4,993
Nonconsolidated Subsidiaries [Member]
Investments in nonconsolidated subsidiaries, beginning	4,993
Investments in nonconsolidated subsidiaries		5,031
Equity in losses of nonconsolidated subsidiaries	(444)	(38)
Translation adjustment	(120)
Investments in nonconsolidated subsidiaries, ending	$ 4,429	$ 4,993

INVESTMENTS IN NONCONSOLIDATE50

INVESTMENTS IN NONCONSOLIDATED SUBSIDIARIES (Details 1) - Nonconsolidated Subsidiaries [Member] - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Assets
Current Assets	$ 2,735	$ 2,753
Property, plant and equipment, net of accumulated depreciation	16,167	18,109
Other Non-Current Assets	7,970	6,054
Total Assets	26,872	26,916
Liabilities and Shareholders' Equity
Current Liabilities	8,221	4,697
Long Term Liabilities	14,282	17,286
Total Liabilities	22,503	21,983
Total Shareholders' Equity	4,369	4,933
Total Liablities and Shareholders'Equity	$ 26,872	$ 26,916

CURRENT MATURITIES OF DEBENTU51

CURRENT MATURITIES OF DEBENTURES AND LONG TERM LOANS (Details Narrative) - USD ($) $ in Thousands		Dec. 31, 2016	Dec. 31, 2015
Debentures		$ 2,658
Current Maturities portion of Loan from Helios	[1]	289	516
Current Maturities Long Term Loan from Bank		41	32
Total Current Maturities of Debentures and Long Term Loans		$ 2,988	$ 549
Debentures [Member]
Interest rate		11.00%
Helios Loan Agreement [Member]
Interest rate		14.50%
Long Term Loan from Bank [Member] | Minimum [Member]
Interest rate		1.80%
Long Term Loan from Bank [Member] | Maximum [Member]
Interest rate		6.00%
[1]	In 2015, the Company entered into a Long Term Mezzanine Loan Agreement (the "Helios Loan Agreement") with Helios Italy Bio-Gas 1 L.P. ("Helios") to finance the acquisition of the SPVs. Under the Helios Loan Agreement, the Company borrowed Euro2,900 ($3,149) at annual interest rate of fourteen and one-half percent (14.5%), paid quarterly. Helios is also entitled to an annual operation fee of one and one-half percent (1.5%), paid quarterly. The final payment of the loan will become due no later than the earlier of (a) thirteen and one half years from the date such loan was made available to the Company, and (b) the date that the Feed in Tariff license granted to the relevant SVP expires. Pursuant to the Helios Loan Agreement, the Company pledged all its shares in Eastern and Bluesphere Pavia to secure the outstanding balance under the Helios Loan Agreement.

SHORT TERM LOAN (Details Narrat

SHORT TERM LOAN (Details Narrative) - USD ($) $ in Thousands	Dec. 14, 2016	Oct. 25, 2016	Jun. 02, 2015	Dec. 31, 2015	Dec. 31, 2016	Sep. 30, 2015
Value of common stock issued upon new issue	$ 84		$ 146	$ 215	$ 717	$ 347
Promissory Notes [Member]
Face value of notes and warrants issued					750
Accrued interest					39
Value of common stock issued upon new issue					188
Fair value of warrants issued					$ 322
Percentage of common shares issued					25.00%
Private Placement [Member] | Investor [Member] | Securities Purchase Agreement [Member]
Face value of notes and warrants issued		$ 1,000,000
Funding at closing		500
Guaranteed financing upon milestone		250
Additional financing		$ 250

ACCRUED SEVERANCE PAY (Details

ACCRUED SEVERANCE PAY (Details Narrative) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended	12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Dec. 31, 2016
Compensation Related Costs [Abstract]
Severance pay expenses	$ 1	$ 2	$ 24

LONG TERM LOANS AND LIABILITI54

LONG TERM LOANS AND LIABILITIES (Details Narrative) - Helios Loan Agreement [Member] - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Debt amount		$ 3,149
Interest rate	16.00%	14.50%
Percentage of outstanding purchase price	50.00%
Interest on unpaid balance	2.00%
Percentage of annual operation fee		1.50%
Euro
Debt amount		$ 2,900

LONG TERM LOANS AND LIABILITI55

LONG TERM LOANS AND LIABILITIES (Details) - USD ($) $ in Thousands		Dec. 31, 2016	Dec. 31, 2015
Deferred payment due to the acquisition of the SPVs	[1]	$ 2,685	$ 2,910
Long Term portion of Loan from Helios	[2]	2,607	3,149
Total Long-term loans and liabilities		5,292	6,059
Less: current maturities of Long Term portion of Loan from Helios	[2]	289	516
Long-term loans and liabilities		$ 5,003	$ 5,543
Deferred payment due to the acquisition of the SPVs [Member]
Interest rate for long term loans and liabilities		2.00%
Helios Loan Agreement [Member]
Interest rate for long term loans and liabilities		16.00%	14.50%
Helios Loan Agreement [Member]
Interest rate for long term loans and liabilities		14.50%
[1]	Represents the remaining balance of fifty percent (50%) of the Purchase Price that is due to the Sellers on the third anniversary of the closing date. This amount will be adjusted to the variation of EBITDA as described above and is promised by a note to each Seller, to be paid on the third anniversary of the closing, along with interest on the unpaid balance due at an annual rate of two percent (2%). The fair value measurement of the fair market value of the remaining balance is based on significant inputs not observed in the market and thus represents a Level 3 measurement, which reflects the Company's own assumptions in measuring fair value. The Company estimated the fair value of the remaining balance using the discounted cash flow model. Key assumptions include the level and timing of the expected future payment and discount rate consistent with the level of risk and economy in general. The balance of the Deferred payment due to the acquisition of the SPVs is included in long term loans and Liabilities in the consolidated Balance Sheets and the change in fair value of remaining balance is included in interest expenses in the consolidated statements of income.
[2]	In 2015, the Company entered into a Long Term Mezzanine Loan Agreement (the "Helios Loan Agreement") with Helios Italy Bio-Gas 1 L.P. ("Helios") to finance the acquisition of the SPVs. Under the Helios Loan Agreement, the Company borrowed Euro2,900 ($3,149) at annual interest rate of fourteen and one-half percent (14.5%), paid quarterly. Helios is also entitled to an annual operation fee of one and one-half percent (1.5%), paid quarterly. The final payment of the loan will become due no later than the earlier of (a) thirteen and one half years from the date such loan was made available to the Company, and (b) the date that the Feed in Tariff license granted to the relevant SVP expires. Pursuant to the Helios Loan Agreement, the Company pledged all its shares in Eastern and Bluesphere Pavia to secure the outstanding balance under the Helios Loan Agreement.

DEBENTURES (Details Narrative)

DEBENTURES (Details Narrative) $ / shares in Units, € in Thousands, $ in Thousands	Dec. 23, 2015USD ($)	Dec. 31, 2015EUR (€)	Dec. 31, 2016USD ($)	May 18, 2016$ / shares	Nov. 01, 2015USD ($)$ / sharesshares
Exercise price (in dollars per shares)				$ 0.058
Amortization expenses of debenture		€ 11	$ 298
Senior Debentures [Member]
Offering amount | $					$ 3,000
Number of shares called by warrant | shares					8,000,000
Gross proceeds from debenture offering subscription agreement | $	$ 3,000
Senior Debentures [Member] | First 50% [Member]
Exercise price (in dollars per shares)					$ 0.05
Senior Debentures [Member] | Second 50% [Member]
Exercise price (in dollars per shares)					$ 0.075

WARRANTS LIABILITY (Details Nar

WARRANTS LIABILITY (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2016	May 18, 2016	Dec. 31, 2015
Exercise price (in dollars per shares)		$ 0.058
November 2015 Warrants ($0.05 per share) [Member]
Exercise price (in dollars per shares)	$ 0.05
November 2015 Warrants ($0.075 per share) [Member]
Exercise price (in dollars per shares)	$ 0.075
November 2015 Offering [Member]
Exercisable date of warrants	Dec. 22, 2020
Estimated fair value of warrants	$ 209
November 2015 Offering [Member] | Maxim Group LLC [Member]
Exercise price (in dollars per shares)	$ 0.06875
Exercisable date of warrants	Dec. 22, 2020
Estimated fair value of warrants	$ 117
Warrant [Member]
Exercise price (in dollars per shares)	$ 0.0901		$ 0.06825
February 3, 2016 Warrants ($0.06 per share) [Member]
Exercise price (in dollars per shares)	$ 0.06
Exercisable date of warrants	Feb. 2, 2019
Estimated fair value of warrants	$ 87
February 2016 Offering ($0.10 per share) [Member]
Exercise price (in dollars per shares)	$ 0.10
Exercisable date of warrants	Feb. 14, 2021
Estimated fair value of warrants	$ 847
February 2016 Offering ($0.061 per share) [Member]
Exercise price (in dollars per shares)	$ 0.061
February 2016 Offering ($0.061 per share) [Member] | Maxim Group LLC [Member]
Exercise price (in dollars per shares)	0.0605
February 2016 Offering ($0.11 per share) [Member]
Exercise price (in dollars per shares)	0.11
February 2016 Offering ($0.11 per share) [Member] | Maxim Group LLC [Member]
Exercise price (in dollars per shares)	$ 0.11
February 2016 Offering [Member]
Exercisable date of warrants	Jul. 25, 2021
February 2016 Offering [Member] | Maxim Group LLC [Member]
Exercisable date of warrants	Feb. 14, 2021
Estimated fair value of warrants	$ 204
July 2016 Offering [Member] | Maxim Group LLC [Member]
Exercise price (in dollars per shares)	$ 0.11
Estimated fair value of warrants	$ 1,140
July 2016 Offering ($0.121c per share) [Member]
Exercise price (in dollars per shares)	$ 0.121
July 2016 Offering ($0.121c per share) [Member] | Maxim Group LLC [Member]
Exercise price (in dollars per shares)	0.121
July 2016 Offering ($0.083 per share) [Member]
Exercise price (in dollars per shares)	0.083
July 2016 Offering ($0.083 per share) [Member] | Maxim Group LLC [Member]
Exercise price (in dollars per shares)	$ 0.083
July 2016 Offering [Member] | Maxim Group LLC [Member]
Exercisable date of warrants	Jul. 25, 2021
Estimated fair value of warrants	$ 117
October 2016 Offering ($0.075 per shares) [Member]
Exercise price (in dollars per shares)	$ 0.075
Exercisable date of warrants	Oct. 24, 2021
Estimated fair value of warrants	$ 504
Warrants exercisable	6,666,666
Exercisable date of balance warrants	Dec. 19, 2021

WARRANTS LIABILITY (Details)

WARRANTS LIABILITY (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended	12 Months Ended
		Dec. 21, 2015	Dec. 21, 2016	Dec. 31, 2016	May 18, 2016	Dec. 31, 2015
Fair Value, Option, Qualitative Disclosures Related to Election [Line Items]
Average exercise price					$ 0.058
May 1, 2014 Warrants ($0.10 per share) [Member]
Fair Value, Option, Qualitative Disclosures Related to Election [Line Items]
Warrants outstanding				1,500,000		1,500,000
Fair value of Warrants Liabilities				$ 26
Average exercise price				$ 0.10
November 2015 Warrants ($0.05 per share) [Member]
Fair Value, Option, Qualitative Disclosures Related to Election [Line Items]
Warrants outstanding	[1]			4,000,000		4,000,000
Fair value of Warrants Liabilities	[1]			$ 155		$ 175
Average exercise price				$ 0.05
November 2015 Warrants ($0.075 per share) [Member]
Fair Value, Option, Qualitative Disclosures Related to Election [Line Items]
Warrants outstanding	[1]			4,000,000		4,000,000
Fair value of Warrants Liabilities	[1]			$ 128		$ 174
Average exercise price				$ 0.075
November 2015 Warrants ($0.06875c per share) [Member]
Fair Value, Option, Qualitative Disclosures Related to Election [Line Items]
Warrants outstanding	[1]			4,480,000		4,480,000
Fair value of Warrants Liabilities	[1]			$ 150		$ 195
Average exercise price				$ 0.06875
February 3, 2016 Warrants ($0.06 per share) [Member]
Fair Value, Option, Qualitative Disclosures Related to Election [Line Items]
Warrants outstanding	[2]			1,500,000
Fair value of Warrants Liabilities	[2]			$ 42
Average exercise price				$ 0.06
February 2016 Offering ($0.10 per share) [Member]
Fair Value, Option, Qualitative Disclosures Related to Election [Line Items]
Warrants outstanding	[3]			17,500,000
Fair value of Warrants Liabilities	[3]			$ 485
Average exercise price				$ 0.10
February 2016 Offering ($0.061 per share) [Member]
Fair Value, Option, Qualitative Disclosures Related to Election [Line Items]
Warrants outstanding	[3]			2,800,000
Fair value of Warrants Liabilities	[3]			$ 101
Average exercise price				$ 0.061
February 2016 Offering ($0.11 per share) [Member]
Fair Value, Option, Qualitative Disclosures Related to Election [Line Items]
Warrants outstanding	[3]			1,400,000
Fair value of Warrants Liabilities	[3]			$ 36
Average exercise price				$ 0.11
July 2016 Offering ($0.11 per share) [Member]
Fair Value, Option, Qualitative Disclosures Related to Election [Line Items]
Warrants outstanding	[4]			18,266,668
Fair value of Warrants Liabilities	[4]			$ 512
Average exercise price				$ 0.11
July 2016 Offering ($0.121c per share) [Member]
Fair Value, Option, Qualitative Disclosures Related to Election [Line Items]
Warrants outstanding	[4]			928,000
Fair value of Warrants Liabilities	[4]			$ 25
Average exercise price				$ 0.121
July 2016 Offering ($0.083 per share) [Member]
Fair Value, Option, Qualitative Disclosures Related to Election [Line Items]
Warrants outstanding	[4]			928,000
Fair value of Warrants Liabilities	[4]			$ 30
Average exercise price				$ 0.083
October 2016 Offering ($0.075 per shares) [Member]
Fair Value, Option, Qualitative Disclosures Related to Election [Line Items]
Warrants outstanding	[5]			10,000,000
Fair value of Warrants Liabilities	[5]			$ 353
Average exercise price				$ 0.075
Warrant [Member]
Fair Value, Option, Qualitative Disclosures Related to Election [Line Items]
Warrants outstanding				67,302,668		13,980,000
Fair value of Warrants Liabilities				$ 2,045		$ 544
Average date to maturity (in years)		4 years 9 months 11 days	4 years 3 months
Average exercise price				$ 0.0901		$ 0.06825
[1]	Pursuant to the November 2015 Offering, the Company sold warrants to purchase up to 4,000,000 shares of Common Stock at an exercise price per share of $0.05 and warrants to purchase up to 4,000,000 shares of Common Stock at an exercise price per share of $0.075. The Warrants are exercisable until December 22, 2020 and were accounted for as derivative liabilities. The Company has estimated the fair value of such warrants at a value of $209 at the date of issuance using the Black-Scholes option pricing model using the following assumptions:
[2]	On February 3, 2016, the Company issued warrants to purchase up to 1,500,000 shares of our common stock of the Company at an exercise price of $0.06 per share, in full satisfaction of certain obligations of the Company. The Warrants are exercisable until February 2, 2019 and were accounted for as derivative liabilities. The Company has estimated the fair value of such warrants at a value of $87 at the date of issuance using the Black-Scholes option pricing model using the following assumptions:
[3]	Pursuant to the February 2016 Offering, the Company sold warrants to purchase up to 17,500,000 shares of Common Stock at an exercise price per share of $0.10. The Warrants are exercisable until February 14, 2021 and were accounted for as derivative liabilities. The Company has estimated the fair value of such warrants at a value of $847 at the date of issuance using the Black-Scholes option pricing model using the following assumptions:
[4]	Pursuant to the July 2016 Offering, the Company sold warrants to purchase up to 18,266,668 shares of Common Stock at an exercise price per share of $0.11. The Warrants are exercisable until July 25, 2021 and were accounted for as derivative liabilities. The Company has estimated the fair value of such warrants at a value of $1,140 at the date of issuance using the Black-Scholes option pricing model using the following assumptions:
[5]	Pursuant to the October 2016 Offering, the Company sold warrants to purchase up to 10,000,000 shares of Common Stock at an exercise price per share of $0.075. 6,666,666 Warrants are exercisable until October 24, 2021 and the balance are exercisable until December 19, 2021. The warrants were accounted for as derivative liabilities. The Company has estimated the fair value of such warrants at a value of $504 at the date of issuances using the Black-Scholes option pricing model using the following assumptions:

WARRANTS LIABILITY (Details 1)

WARRANTS LIABILITY (Details 1) - November 2015 Offering [Member]	12 Months Ended
	Dec. 31, 2016
Fair Value, Option, Qualitative Disclosures Related to Election [Line Items]
Dividend yield	0.00%
Risk-free interest rate	1.74%
Expected term (years)	5 years
Volatility	202.00%

WARRANTS LIABILITY (Details 2)

WARRANTS LIABILITY (Details 2) - Maxim Group LLC [Member] - November 2015 Warrants ($0.06875c per share) [Member]	12 Months Ended
	Dec. 31, 2016
Dividend yield	0.00%
Risk-free interest rate	1.74%
Expected term (years)	5 years
Volatility	202.00%

WARRANTS LIABILITY (Details 3)

WARRANTS LIABILITY (Details 3) - February 3, 2016 Warrants ($0.06 per share) [Member]	12 Months Ended
	Dec. 31, 2016
Fair Value, Option, Qualitative Disclosures Related to Election [Line Items]
Dividend yield	0.00%
Risk-free interest rate	1.20%
Expected term (years)	3 years
Volatility	203.00%

WARRANTS LIABILITY (Details 4)

WARRANTS LIABILITY (Details 4) - February 2016 Offering ($0.10 per share) [Member]	12 Months Ended
	Dec. 31, 2016
Fair Value, Option, Qualitative Disclosures Related to Election [Line Items]
Dividend yield	0.00%
Risk-free interest rate	1.20%
Expected term (years)	5 years
Volatility	203.00%

WARRANTS LIABILITY (Details 5)

WARRANTS LIABILITY (Details 5) - Maxim Group LLC [Member] - February 2016 Offering [Member]	12 Months Ended
	Dec. 31, 2016
Dividend yield	0.00%
Risk-free interest rate	1.20%
Expected term (years)	5 years
Volatility	203.00%

WARRANTS LIABILITY (Details 6)

WARRANTS LIABILITY (Details 6) - July 2016 Offering ($0.11 per share) [Member]	12 Months Ended
	Dec. 31, 2016
Fair Value, Option, Qualitative Disclosures Related to Election [Line Items]
Dividend yield	0.00%
Risk-free interest rate	1.00%
Expected term (years)	5 years
Volatility	147.00%

WARRANTS LIABILITY (Details 7)

WARRANTS LIABILITY (Details 7) - Maxim Group LLC [Member] - July 2016 Offering [Member]	12 Months Ended
	Dec. 31, 2016
Dividend yield	0.00%
Risk-free interest rate	1.00%
Expected term (years)	5 years
Volatility	147.00%

WARRANTS LIABILITY (Details 8)

WARRANTS LIABILITY (Details 8) - October 2016 Offering ($0.075 per shares) [Member]	12 Months Ended
	Dec. 31, 2016
Dividend yield	0.00%
Expected term (years)	5 years
Minimum [Member]
Risk-free interest rate	1.75%
Volatility	77.00%
Maximum [Member]
Risk-free interest rate	2.04%
Volatility	89.00%

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands	Dec. 14, 2016	Dec. 02, 2015	Jun. 02, 2015	Jul. 31, 2015	Dec. 31, 2015	Dec. 31, 2016	Sep. 30, 2015	Dec. 18, 2015
Common shares issued in offerings (shares)	7,658,129		13,930,742
Value of common stock issued upon new issue	$ 84		$ 146		$ 215	$ 717	$ 347
Mr. Shlomi Palas [Member] | Promissory Note [Member]
Debt face amount								$ 129
Accredited Investors [Member] | Offering [Member]
Aggregate gross proceeds from closings of offerings		$ 225		$ 250
Share price (in dollars per share)		$ 0.0104		$ 0.0176
Common shares issued in offerings (shares)		21,588,871

CONTINGENT AND COMMITMENTS (Det

CONTINGENT AND COMMITMENTS (Details Narrative) - JS Barkats PLLC [Member] - USD ($) $ in Thousands	Oct. 26, 2016	Apr. 23, 2012
Loss Contingencies [Line Items]
Legal fees		$ 428
Legal fees including interest		$ 652
Value of transferring or dissipating assets	$ 652

COMMON SHARES (Details Narrativ

COMMON SHARES (Details Narrative)	Dec. 20, 2016shares	Dec. 14, 2016USD ($)shares	Aug. 16, 2016shares	Aug. 07, 2016shares	Jul. 17, 2015USD ($)shares	Jul. 06, 2015USD ($)shares	Jul. 02, 2015USD ($)shares	Jun. 12, 2015USD ($)shares	Jun. 02, 2015USD ($)shares	Apr. 15, 2015USD ($)shares	Apr. 13, 2015USD ($)shares	Mar. 12, 2015USD ($)shares	Jan. 05, 2015USD ($)$ / sharesshares	Dec. 08, 2014shares	Oct. 28, 2014shares	Oct. 03, 2014USD ($)$ / sharesshares	Aug. 31, 2015USD ($)shares	Jul. 31, 2015USD ($)shares	May 31, 2015USD ($)shares	Mar. 19, 2015USD ($)shares	Oct. 31, 2014USD ($)Number	Jun. 30, 2015USD ($)shares	Dec. 31, 2015USD ($)	Aug. 31, 2015USD ($)Number	Dec. 31, 2016USD ($)	Sep. 30, 2015USD ($)	May 18, 2016$ / shares
Issuance of shares for services (in shares)	850,000		400,000	143,000
Value of common stock issued for services | $																							$ 136,000		$ 745,000	$ 1,574,000
Issuance of common stock (in shares)		7,658,129							13,930,742
Value of common stock issued upon new issue | $		$ 84,000							$ 146,000														$ 215,000		$ 717,000	$ 347,000
Beneficial principal loan converted | $																								$ 1,480,716
Number of shares issued upon conversion | Number																								75,060,414
Exercise price (in dollars per share) | $ / shares																											$ 0.058
Service Agreement [Member]
Issuance of shares for services (in shares)															335,000
Investor [Member]
Issuance of shares for services (in shares)												109,039						8,035,000	3,250,000	6,114,867		3,765,000
Value of common stock issued for services | $												$ 14,000						$ 199,000	$ 136,000	$ 738,000		$ 150,000
Beneficial principal loan converted | $																					$ 42,000
Number of shares issued upon conversion | Number																					471,967
Dr. Borenstein Ltd (Subscription Agreement) [Member]
Exercise price (in dollars per share) | $ / shares													$ 0.001
Non-US Personnel (Subscription Agreement) [Member]
Issuance of common stock (in shares)					2,318,183
Value of common stock issued upon new issue | $					$ 39,000
Non-US Entity (Subscription Agreement) [Member]
Issuance of common stock (in shares)						2,428,571
Value of common stock issued upon new issue | $						$ 51,000
Dr. Borenstein Ltd (Subscription Agreement) [Member]
Issuance of common stock (in shares)								8,484,848		1,630,000
Value of common stock issued upon new issue | $								$ 140,000		$ 48,000
Number of shares options to purchase													1,000,000
Value of common stock options | $													$ 158,000
Non-US Person (Subscription Agreement) [Member]
Issuance of common stock (in shares)							2,000,000				416,667
Value of common stock issued upon new issue | $							$ 32,000				$ 25,000
Carter Terry [Member]
Issuance of shares for services (in shares)														209,000
Non-US Citizen (Consulting Agreement) [Member]
Issuance of shares for services (in shares)																2,000,000
Value of common stock issued for services | $																$ 217,000
Number of shares options to purchase																500,000
Exercise price of options (in dollars per share) | $ / shares																$ 0.001
Non-US Person (Financial Advisor & Investment Banker Settlement Agreement) [Member]
Issuance of shares for services (in shares)																	1,128,237
Value of common stock issued for services | $																	$ 13,000
Maxim Group LLC [Member]
Issuance of shares for services (in shares)																	3,474,405
Value of common stock issued for services | $																	$ 34,000

COMMON SHARES (Details Narrat70

COMMON SHARES (Details Narrative 1) - USD ($)	Dec. 30, 2016	Dec. 20, 2016	Dec. 14, 2016	Oct. 25, 2016	Sep. 15, 2016	Aug. 16, 2016	Aug. 07, 2016	Jul. 14, 2016	Jun. 13, 2016	Jun. 02, 2016	May 18, 2016	Apr. 13, 2016	Mar. 15, 2016	Feb. 15, 2016	Feb. 01, 2016	Jan. 26, 2016	Jun. 02, 2015	Jul. 31, 2016	Mar. 31, 2016	Dec. 31, 2015	Jun. 30, 2016	Dec. 31, 2016	Sep. 30, 2015	Jun. 17, 2016
Issuance of common stock (in shares)			7,658,129														13,930,742
Issuance of shares for services (shares)		850,000				400,000	143,000
Issuance of shares for services		$ 50,000				$ 24,000	$ 11,000													$ 136,000	$ 73,000	$ 745,000	$ 1,574,000
Warrant exercise term											1 year 6 months
Exercise price (in dollars per share)											$ 0.058
Issuance of common stock upon exercise of warrants (shares)											700,000
Issuance of common stock upon exercise of warrants											$ 41,000
Amount of issuance of common stock			$ 84,000														$ 146,000			$ 215,000		$ 717,000	$ 347,000
Number of shares cancel								85,000
2014 Incentive Plan [Member]
Issuance of shares for services (shares)									7,103,467
Issuance of shares for services									$ 632,000
Global Share and Options Incentive Enhancement Plan (2014) [Member]
Issuance of shares for services (shares)	5,775,000
Issuance of shares for services	$ 386,000
Mr. Joshua Shoham [Member]
Issuance of shares for services (shares)		950,000
Mr. Amitzur [Member]
Issuance of shares for services (shares)	850,000
Issuance of shares for services	$ 24,000
Board of Directors [Member]
Issuance of shares for services (shares)	300,000
Issuance of shares for services	$ 20,000
Mr. Shlomi Palas [Member]
Issuance of shares for services (shares)		85,000
February 2016 Offering [Member]
Gross proceeds from subscription agreement														$ 1,925,000
Warrant exercise term														5 years
Exercise price (in dollars per share)														$ 0.10
Securities sold in offering (percent)														50.00%
Stock shares subscribed														35,000,000
Stock price														$ 0.055
Number of shares called by warrant														17,500,000
February 2016 Offering [Member] | Maxim Group LLC [Member]
Exercise price (in dollars per share)														$ 0.0605
Number of shares called by warrant														2,800,000
February 2016 Offering [Member] | Maxim Group LLC [Member] | Warrant [Member]
Stock shares subscribed														1,400,000
Stock price														$ 0.11
Commision rate (percent)														7.00%
July 2015 Offering Subscription Agreements [Member]
Issuance of common stock (in shares)										13,930,742
Amount of issuance of common stock										$ 146,000
June 2016 Offering [Member]
Gross proceeds from subscription agreement																		$ 3,000,000
Securities sold in offering (percent)																		100.00%
Stock price																		$ 0.011
June 2016 Offering [Member] | Warrant [Member]
Issuance of shares for services (shares)																		1,000,000
Gross proceeds from subscription agreement																		$ 1,370,000
Warrant exercise term																		5 years
Exercise price (in dollars per share)																		$ 0.11
Stock shares subscribed																		18,266,668
Stock price																		$ 0.075
Number of shares called by warrant																		18,266,668
June 2016 Offering [Member] | Maxim Group LLC [Member]
Exercise price (in dollars per share)																		$ 0.0825
Stock shares subscribed																		928,000
Stock price																		$ 0.121
Number of shares called by warrant																		928,000
June 2016 Offering [Member] | Maxim Group LLC [Member] | Warrant [Member]
Commision rate (percent)																		4.44%
Consultant One [Member]
Issuance of shares for services (shares)					500,000							875,000			540,000
Issuance of shares for services					$ 20,000							$ 42,000			$ 108,000
Consultant [Member]
Issuance of shares for services (shares)									1,000,000			1,000,000	85,000
Issuance of shares for services									$ 89,000				$ 5,685						$ 10,000
Consultant Two [Member]
Issuance of shares for services (shares)					500,000
Issuance of shares for services					$ 34,000
Subscription Agreements [Member]
Issuance of common stock (in shares)																1,000,000
Issuance of shares for services (shares)			7,658,129
Issuance of shares for services			$ 84,000
Securities Purchase Agreement [Member]
Issuance of shares for services		$ 250,000		$ 500,000
Mutual Agreement [Member]
Issuance of shares for services				$ 250,000
Share Purchase Agreement [Member]
Value of share repurchase program																								$ 500,000,000
Number of shares authorized for repurchase																								7,473,841

COMMON SHARES (Details)

COMMON SHARES (Details) - shares	Dec. 31, 2016	Dec. 31, 2015
Stockholders' Equity Note [Abstract]
Outstanding warrants to purchase common stock	67,302,668	13,980,000
Outstanding Options to purchase common stock	778,761	778,761
Approved but not Outstanding Options to purchase common stock		3,175,000
Unvested Common Stock under the 2014 Incentive Plan	962,500	7,316,667
Common Stock reserved under the 2016 Incentive Plan	30,000,000
Option to purchase Common Stock reserved under the 2016 Incentive Plan	15,000,000
Common Stock reserved under the October 2016 Offering	57,000,000
Total shares reserved for issuance	171,043,929	25,250,428

STOCK OPTIONS AND STOCK INCEN72

STOCK OPTIONS AND STOCK INCENTIVE PLANS (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands	Feb. 24, 2015	Dec. 31, 2016	Dec. 31, 2016
Stock Option [Member]
Aggregated intrinsic value vested and exercisable options		$ 0	$ 0
Weighted average contractual term			1 year 3 months 29 days
Intrinsic value of options		$ 9	$ 9
2010 Plan [Member]
Number of shares available under plan	2,575,000
Common stock issued under plan			2,575,000
2014 Plan [Member]
Number of shares available under plan	13,100,000
Share-based compensation arrangement by share-based payment award, award vesting period	2 years
2014 Plan [Member] | Stock Option [Member]
Number of shares available under plan	3,175,000
Share price (in dollars per share)	$ 0.14
2016 Plan [Member]
Common stock issued under plan		10,733,333
Number of shares permits to issue under plan		30,000,000	30,000,000
2016 Plan [Member] | Stock Option [Member]
Number of shares available under plan		15,000,000	15,000,000
Share-based compensation arrangement by share-based payment award, award vesting period			2 years

STOCK OPTIONS AND STOCK INCEN73

STOCK OPTIONS AND STOCK INCENTIVE PLANS (Details)	12 Months Ended
	Dec. 31, 2016$ / sharesshares
Number of options:
Outstanding | shares	778,761
Number of options vested and exercisable | shares	778,761
Weighted Average Exercise Price:
Outstanding | $ / shares	$ 0.5763
Number of options vested and exercisable | $ / shares	$ 0.5763
Weighted Average Remaining Contractual Life (Years)	1 year 3 months 29 days

INCOME TAXES (Details Narrative

INCOME TAXES (Details Narrative) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Statutory income tax rate			35.00%	35.00%
Net operating loss carry-forward			$ 20,635
Israeli Subsidiaries [Member]
Effective income tax rate	23.00%	24.00%	25.00%	26.50%
Net operating loss carry-forward			$ 4,114

INCOME TAXES (Details)

INCOME TAXES (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Deferred tax assets:
Net operating loss carry-forward	$ 9,259	$ 6,768
Valuation allowance	$ (9,259)	$ (6,768)

INCOME TAXES (Details 1)

INCOME TAXES (Details 1) $ in Thousands	12 Months Ended
	Dec. 31, 2016USD ($)
Income Tax Disclosure [Abstract]
Valuation allowance, begining	$ 6,768
Increase	2,491
Valuation allowance, ending	$ 9,259

INCOME TAXES (Details 2)

INCOME TAXES (Details 2) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Income Tax Disclosure [Abstract]
Loss before taxes, as reported in the consolidated statements of operations	$ 7,266	$ 7,462
Federal statutory rate	35.00%	35.00%
Theoretical tax benefit on the above amount at federal statutory tax rate	$ 2,543	$ 2,611
Losses and other items for which a valuation allowance was provided or benefit from loss carry forward	(2,491)	$ (2,611)
Actual tax expense	$ 52

TRANSITION PERIOD FINANCIAL I78

TRANSITION PERIOD FINANCIAL INFORMATION (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2016	Sep. 30, 2015
Transition Period Financial Information Details
General and administrative expenses	$ 1,106	$ 827	$ 7,516	$ 5,317
Other losses		19
Financial expenses. net	144	468
Equity Losses in Non- Consolidated Subsidiaries	38
Net Loss	$ 1,288	$ 1,314	$ 1,801	$ 7,462
Net loss per common share - basic and diluted (in dollars per share)	$ (0.007)	$ (0.026)	$ (0.008)	$ (0.088)
Weighted average number of common shares outstanding during the period - basic and diluted (in shares)	177,011,554	51,031,823	235,909,374	85,135,631

TRANSITION PERIOD FINANCIAL I79

TRANSITION PERIOD FINANCIAL INFORMATION (Details 1) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Dec. 31, 2014	Sep. 30, 2014
Transition Period Financial Information Details 1
Total Current Assets	$ 1,905	$ 3,303		$ 404
Total Non-Current Assets				509
Total assets	16,521	15,896		913
Total Current liabilities	11,574	10,808		1,234
Long Tern Bank Loan	112	127		126
Total stockholders' equity	(2,224)	(3,486)	$ (2,694)	(447)	$ 310
Total liabilities and Stockholders' Deficit	$ 16,521	$ 15,896		$ 913

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - USD ($)	Feb. 01, 2017	Jan. 31, 2017	Dec. 14, 2016	Jun. 02, 2015	Feb. 13, 2017
Issuance of common stock (in shares)			7,658,129	13,930,742
Subsequent Event [Member] | Loans Agreement [Member]
Debt amount					$ 200,000
Interest rate					10.00%
Subsequent Event [Member] | Non-Employee Director Compensation Policy [Member] | Eligible Director [Member]
Annual cash retainer	$ 20,000
Value of stock awards paid quarterly	13,000
Meeting fees (in person)	500
Meeting fees (teleconference)	500
Special meeting fees of Board	250
Meeting fees of a committees of the Board	$ 500
Meeting fees of a committees of the Board (percent)	50.00%
Subsequent Event [Member] | Chief Financial Officer [Member] | ISRAEL
Issuance of common stock (in shares)		404,167
Subsequent Event [Member] | Chief Financial Officer [Member] | UNITED STATES
Issuance of common stock (in shares)		350,000